Skip to main content
Scotland Flag Scotland Flag Scotland Flag

Record Number In Scotland Buy Legal Medical Cannabis Privately

Written by Hazel Norman on . Posted in Business, Policy.

Scotland’s legal medical cannabis industry has struggled to reach its full potential in recent years, however, the industry has passed a meaningful milestone with a record number of Scots making legal purchases of medical cannabis products from private industry sources.

“Record numbers of Scots are paying for medical cannabis as NHS waiting lists leave them struggling to get conventional treatment.” reported Daily Mail. “An unprecedented 3,440 Scots now have private prescriptions for the drug – mostly patients suffering from common conditions such as depression, anxiety, or chronic pain.”

“Scotland’s first medical cannabis clinic was set up in 2019 and its roster of clients has grown monthly.” the outlet also reported.

Nearly five dozen nations around the world have legalized cannabis for medical use to some degree. Israel was the first country to legalize cannabis for medical use back in 1999.

Currently, cannabis is legal for adult use in Uruguay, Canada, Malta, Luxembourg, Germany, and South Africa. Recreational cannabis legalization has also been adopted by two dozen states in the U.S., and regional adult-use cannabis commerce pilot trials are operating in the Netherlands and Switzerland.

Bundestag Germany Parliament Bundestag Germany Parliament Bundestag Germany Parliament

Poll: 63.83% Consider Complete CanG Reversal To Be Unlikely

Written by Johnny Green on . Posted in Business, Policy.

In the aftermath of a recent federal election in Germany, a majority of the nation’s cannabis industry members consider a complete reversal of the CanG law to be ‘unlikely’ according to a recent poll conducted by the German Cannabis Business Association (BvCW).

BvCW, in its recent poll, asked, “After the federal election: How likely do you think it is that the CanG will be completely reversed?”

The results of the survey found that a combined 63.83% consider a complete reversal to be ‘very unlikely’ or ‘rather unlikely,’ 19.15% consider a partial reversal to be likely, 6.38% responded with ‘rather likely,’ and 8.51% consider it to be ‘very likely.’

Starting on April 1st, 2024, adults in Germany can cultivate and possess a personal amount of cannabis. Additionally, starting on July 1st, 2024, people in Germany can apply to start a cultivation association. Also, cannabis was removed from Germany’s Narcotics List as part of the enactment of the CanG law.

Another major component of the CanG law, which would permit regional adult-use cannabis commerce pilot trials, has yet to launch. Pilot trials were expected to launch late last year. However, after the recent federal election, the launch date for pilot trials is in question.

Leading up to the federal election in Germany, the International Cannabis Business Conference reached out to Germany-based international cannabis policy expert Peter Homberg of gunnercooke for his thoughts.

Peter Homberg predicted that the election would yield a coalition government, which time has proven to be true. Homberg also made another prediction at the time.

“Many statements being made right now from cannabis opponents are being made in an ‘election mode’ and will not necessarily become reality. I expect extreme positions to level out after the election.” Homberg stated at the time regarding candidates campaigning on reversing the CanG law.

As we previously reported, the New Association of Judges (NRV) in Germany recently expressed a positive conclusion regarding legalization and warned newly elected German lawmakers against reversing the CanG law.

“Rolling back the law would mean that the judiciary would have to pursue small consumers on a large scale again. This would mean there would be no time to take action against organized crime.” reported Deutschlandfunk in its local coverage.

“In addition, according to the NRV, the state faces high compensation payments in the event of withdrawal. If the cultivation and consumption of cannabis were to be completely banned again, this would amount to expropriation of the cannabis clubs, it was said. This would enable the clubs to make claims for compensation against the state. The investment in cannabis cultivation is high and the licenses are valid for seven years according to the law.” the outlet also stated.

The Institute for Competition Economics at the Heinrich Heine University in Düsseldorf previously conducted an analysis which found that adult-use legalization could yield as much as 1.3 billion euros per year in savings for Germany’s police and judicial system.

london england britain united kingdom london england britain united kingdom

UK Cannabis Legalization Could Yield £1.5 Billion Annually

Written by Johnny Green on . Posted in Business, Policy.

Adult-use cannabis legalization in the UK could generate as much as £1.5 billion in revenue and savings according to a new report by the advocacy group Transform Drug Policy Foundation.

The report, which was posted on the organization’s social media account, determined that over £1.2 billion would be generated from taxes and fees annually, and an additional £284 million would be saved annually by the nation’s criminal justice system no longer enforcing cannabis prohibition policies.

“There would be costs incurred for Govt by regulatory infrastructure – inspection, monitoring, compliance, trading standards etc – but largely covered by licensing/other fees.” the organization stated on social media.

Transform Drug Policy Foundation also determined that “up to 15,500 full-time jobs could be created in cultivation, manufacturing, retail & related services, (depending on the model implemented).”

The report also found that “a regulated market could displace 80% of the illegal trade in five years (based on trends in Canada).” The organization’s proposed legalization model involves permitting home cultivation, cultivation associations, and a government retail monopoly.

A previous analysis published last year by UK-based advocacy group CLEAR determined that legalizing cannabis for adult use in the United Kingdom and taxing and regulating sales could generate as much as £9.5 billion per year based on their proposed model.

malaysia flag malaysia flag malaysia flag

Malaysia Health Ministry Opens Cannabis-Based Product Registration

Written by Hazel Norman on . Posted in Business, Policy.

A major push for limited medical cannabis policy reform and industry regulations took place in Malaysia in 2022, and the nation passed a major milestone this week with Malaysia’s Health Ministry announcing that registration for medical cannabis-based products is now open.

“Those who have sufficient scientific evidence supporting the use of cannabis-based products for medical treatment can come forward to submit their product registration, says the Health Ministry.” reported The Star in its local coverage.

“However, they must comply with the relevant laws, the ministry said in a written parliamentary reply dated March 3.” the media outlet also reported.

Malaysia’s cannabis policies are largely governed by the Dangerous Drugs Act 1952 and the Poisons Act 1952, both of which classify cannabis and its derivatives as ‘dangerous drugs.’

Historically, the region that Malaysia is located in is where some of the harshest cannabis laws on earth can be found, and in some ways in Malaysia, can still be found.

Malaysia is one of a handful of countries around the world, most of them located in the same region, that still issues the death penalty for certain cannabis-only offenses. With that in mind, any movement towards permitting medical cannabis is significant.

banking bank finance financing financial agreement investing investment banking bank finance financing financial agreement investing investment

Prominent German Financial Institution Enters Cannabis Industry

Written by Johnny Green on . Posted in Business.

Germany’s emerging legal cannabis industry continues to go mainstream, with the latest example of that coming in the form of cannabis company GOC Nexus receiving funding from leading German financial institution Volksbank Donau-Mindel.

Volksbank Donau-Mindel was joined in the successful funding round by a concurrent investment from SYNBIOTIC SE, Germany’s largest publicly listed cannabis company, and was coordinated by leading European cannabis investment firm The Talman House. SYNBIOTIC SE is a member of The Talman House.

Volksbank Donau-Mindel and SYNBIOTIC SE’s funding of GOC Nexus, a cutting-edge cannabis technology company that is revolutionizing the processing of medicinal and recreational cannabis, will create the first production facility of its kind that is compliant with EU-GMP standards.

“Despite significant interest from potential business partners in our services, particularly the microbiological cold plasma treatment of cannabis flowers, many were reluctant to invest upfront.” Stated Dr. David Surjo, CEO of GOC Nexus.

“The initial investments required for a pharmaceutical production facility are substantial, making it impossible to finance entirely from internal resources.” Dr. Surjo said. “After deciding to approach banks, we concentrated on local banks without a presence in the USA or Canada. This was crucial, as international banks often face legal restrictions when dealing with cannabis businesses.”

“We are excited that the cooperative bank Volksbank Donau-Mindel supports our project. Their interest in innovative business models and flexibility were key to our success.” Dr. Surjo also stated.

The significance of this successful funding round cannot be overstated. It is no secret that the legal cannabis industry has struggled to gain consistent access to the world’s banking system, and gaining funding from prominent financial institutions has proven to be particularly difficult for cannabis companies. From that perspective, Volksbank Donau-Mindel’s investment is a very big deal, and a testament to the benefits of cannabis companies becoming members of The Talman House network.

The Talman House is private and exclusive, with dozens of leading cannabis companies already serving as members. It is the largest private network of cannabis investors and executives in Europe and has helped established cannabis companies secure funding, including GOC Nexus.

GOC Nexus’ innovative cold plasma technology designed by an experienced multidisciplinary team, is revolutionizing the cannabis industry through its unique combination of efficiency, product safety, and the preservation of therapeutically valuable compounds.

The company’s patent-pending process combines optimal cleaning performance with careful, gentle treatment. This is achieved through minimal energy input and synergistic cleaning effects of activated plasma particles. Cold plasma processing sets new standards compared to conventional methods. The treatment enhances the product by safely eliminating microbiology while preserving the entourage effect of cannabinoids.

GOC Nexus technology protects the organoleptic properties of the processed material. The terpene profile, essential for the therapeutic entourage effect, remains completely intact. Traditional methods destroy 30-70% of volatile active compounds and destabilize cannabinoids. The trichomes, as production sites of cannabinoids and terpenes, remain undamaged through the gentle cold plasma treatment. This ensures taste, aroma, therapeutic efficacy, and pharmaceutical stability. The optical quality of the flowers is also preserved, increasing patient acceptance.

It is estimated that today more than 50% of cannabis produced worldwide does not meet microbiological requirements. GOC-NEXUS helps cultivators control the microbiological contamination of the final product through a non-thermal, non-radiative remediation service without using any chemical agents.

Exhibitors ICBC Berlin 2024 Exhibitors ICBC Berlin 2024 Exhibitors ICBC Berlin 2024

German Cannabis Business Week – Global Industry To Converge In Berlin

Written by Johnny Green on . Posted in Business.

Germany’s legal cannabis industry is experiencing an unprecedented revolution. Thanks to last year’s adoption of the CanG policy modernization measure, every major sector of the nation’s emerging cannabis industry is experiencing growth.

The German Cannabis Business Week will take place during this pivotal moment, bringing together leaders from across the global cannabis industry to Berlin, Germany, beginning on April 28th, 2025. The week will commence with The Talman House’s exclusive investor gathering, held at the prestigious Hotel Adlon Kempinski, an internationally renowned venue recognized for its historic significance and unmatched hospitality.

This private investor event, reserved for The Talman House members, will serve as a strategic forum where key investors and industry experts will examine evolving market dynamics, investment trends, and regulatory shifts shaping the European cannabis sector. Discussions will center on the economic implications of Germany’s legalization model, the expansion of regulated cannabis markets across the EU, and how investors can navigate the rapidly changing landscape.

Following the Talman House event in Berlin, the International Cannabis Business Conference (ICBC) will once again bring its flagship two-day conference to the iconic Estrel Berlin Hotel on April 29th-30th. ICBC Berlin is Europe’s largest and longest-running cannabis B2B event, and this year’s installment will be bigger and better than ever.

Several important and timely topics will be covered at ICBC Berlin, including Germany’s cultivation associations. As of July 1st, 2024, aspiring cultivation association operators can apply with their local regulatory authorities in Germany. Many association applications are being processed across Germany, with dozens of associations already receiving approval and having launched operations.

Additionally, regional adult-use cannabis commerce pilot projects are expected to launch soon in Germany, and it is sure to be a popular topic at ICBC Berlin. Associations and pilots are expected to proliferate many parts of Germany. Competition is going to increase significantly within Germany’s industry, and a great way to learn how to maximize your opportunities and network with industry leaders is at ICBC Berlin. Register now and save $200 before ticket prices go up on April 2nd at midnight.

Part of the new German CanG law involves permitting adults to cultivate up to three plants in their private residences. Home cultivation legalization is creating a thriving industry sector in Germany. Companies specializing in home cultivation equipment and cannabis genetics are experiencing exponential sales growth within the German market.

Germany’s emerging medical cannabis industry was already the largest in Europe before the nation’s new CanG law took effect. However, since April 1st, 2024, when the first provisions of adult-use legalization became effective in Germany, the nation’s medical cannabis industry has already grown exponentially.

A main contributing factor to the recent growth of Germany’s medical cannabis industry was the removal of cannabis from the nation’s Narcotics List, which was a key component of the new CanG law. The removal of cannabis from the list made it easier for doctors to prescribe cannabis in Germany, in addition to improving the medical cannabis supply chain and boosting domestic medical cannabis production.

Medical cannabis is arguably the biggest winner of Germany’s adult-use policy modernization effort so far, and the boost in patient numbers is still very much in the early stages. Prior to April 1st, researchers estimated that Germany had between 200k and 300k active medical cannabis patients. That number is projected to increase to as much as 5 million in the not-so-distant future. According to a recent report by the Bloomwell Group, prescriptions for medical cannabis in Germany increased by roughly 1,000% between March 2024 and December 2024. Medical cannabis in Germany will be thoroughly discussed throughout German Cannabis Business Week in April.

Over 5,000 cannabis leaders from over 80 countries are expected to be represented at ICBC Berlin 2025 and that includes representatives from every sector of the industry, as well as leading international cannabis policymakers and industry service providers. Bring your company to the International Cannabis Business Conference in Berlin to network with the best and take your industry pursuits to the next level. Register now and save $200 before ticket prices go up on April 2nd at midnight. Make sure to secure your spot before the event sells out.

Additionally, serious entrepreneurs and investors looking to gain a footprint in Europe’s emerging legal cannabis industry should join The Talman House network. The Talman House is private and exclusive, with dozens of leading cannabis companies already serving as members. It is the largest private network of cannabis investors and executives in Europe and has helped established cannabis companies secure funding.

Membership in The Talman House provides numerous benefits, including gaining access to ongoing investor events in Europe such as the April 28th event in Berlin that kicks off German Cannabis Business Week. Joining The Talman House is an effective and efficient way to maximize your company’s potential in both Europe and abroad. You can find out more about how to become a member by contacting the Talman team.

Cannabis plant flower Cannabis plant flower Cannabis plant flower

Argentina To Revoke All Medical Cannabis Production Permits

Written by Hazel Norman on . Posted in Business.

In October 2022, regulators in Argentina issued the nation’s first-ever domestic cannabis production license. However, government officials in Argentina announced this month that it plans to revoke all current medical cannabis cultivation permits.

“The Minister of National Security, Patricia Bullrich announced that the Government will cancel permits to grow marijuana.” InfoBae stated in its local coverage.

“We are going to cancel everything, we are going to start from scratch.” Patricia Bullrich stated according to the media outlet.

In April 2023, Argentina’s government participated in the nation’s first legal hemp harvest in roughly 50 years. Starting in 2019, Argentina has made a big push to boost its domestic cannabis industry, particularly as it pertains to science and research. Back then, Argentina’s Ministry of Science and Technology signed an agreement with a local government, the National University, and other entities.

That was followed by a Presidential decree issued in 2020 which provided a way for medical cannabis patients to, in theory, sign up for a government program in order to be able to cultivate their own medicine.

In May 2022, lawmakers in Argentina passed a measure that created the framework for a more robust medical cannabis industry in the South American nation, including provisions for boosting exports around the world. Later in 2022, the government established a public company to provide seeds, testing, and training to the nation’s emerging medical cannabis industry.

jar of cannabis flower jar of cannabis flower jar of cannabis flower

99.7% Of Cannabis In France Remains Unregulated

Written by Hazel Norman on . Posted in Business, Policy.

As of 2022, the European Union Drugs Agency estimated that France had the greatest cannabis consumption rate of any of its member nations, with a reported 10.6% of France’s population having consumed cannabis at least once within the last year.

Unfortunately, cannabis use by adults for recreational purposes remains illegal in France, and only patients enrolled in the country’s medical cannabis trial experiment are permitted to consume cannabis legally. As such, nearly all of the cannabis consumed in France comes from unregulated sources.

“Despite a strict prohibition policy in France, the figures are clear: after the Place Nette operations, 99.7% of the cannabis circulating in France remained on the black market.” reports Newsweed (translated from French to English).

“This observation highlighted by the NORML France association in a report entitled “Why legalize cannabis in 2025” aims to show the ineffectiveness of repressive measures and raises the question of their relevance in the face of a market that continues to prosper.” the outlet also reported.

Health authorities in France announced late last year that the nation’s medical cannabis trial experiment will be extended until July 31st, 2025. The announcement is welcomed news to the reported 1,800 suffering patients estimated to be currently participating in the trial.

“The experiement was due to end on 31 December 2024, but at a meeting on Thursday between patient associations and the health authorities, the Ministry of Health gave the green light for it to run for a further six months, FranceInfo reported.” stated RFI in its local coverage.

The French medical cannabis experiment received initial approval from the federal Senate back in 2019, however, the launch of the trial was delayed until the spring of 2021 due to various reasons.

Initially slated for two years, France’s medical cannabis experiment was eventually granted a one-year extension and was set to end in 2024 before receiving the latest extension pushing the estimated end of the trial to the summer of 2025.

According to a recent newsletter sent out by international cannabis economist Beau Whitney of Whitney Economics, France is home to the largest total addressable cannabis market in the European Union with a value of $11.3 billion (midpoint).

A previous study by an economic advisory board within the nation’s prime minister’s office determined that the French government spends roughly €570m annually on cannabis prohibition enforcement. The study recommended that France adopt adult-use cannabis legalization and launch a regulated recreational industry.

Emmanuelle Auriol, a professor at the Toulouse School of Economics who authored the study’s report and findings, estimated that such a policy change could create as many as 80,000 new jobs, and generate €2.8bn in taxes annually.

cbd cannabidiol oil hemp tincture cbd cannabidiol oil hemp tincture cbd cannabidiol oil hemp tincture

Spain Cannabis Regulatory Measure Amended To Address CBD Products

Written by Johnny Green on . Posted in Business, Policy.

Lawmakers and regulators in Spain are making what appears to be a final push to finally approve and implement a long-awaited medical cannabis regulatory measure. Spain has long been home to a thriving medical cannabis community and market, however, regulations for the nation’s domestic medical cannabis industry have proved to be elusive for years.

The effort to bring Spain’s medical cannabis policies into the modern age passed a major milestone back in October 2024 when the nation’s Ministry of Health published a draft royal decree focused on medical cannabis. The measure is reportedly moving forward, and was recently amended to address concerns over how it would potentially impact CBD products.

“Thanks to the coordinated lobbying efforts of EIHA, alongside other associations and manufacturers, the Spanish government has amended the draft Royal Decree on cannabis regulation from October 2024.” the European Industrial Hemp Association (EIHA) stated about the amendment.

“The risky sentence “regardless of its cannabinoid content”, which posed a serious threat by potentially classifying CBD as a narcotic, has been replaced with: “preparations with a THC content equal to or greater than 0.2% by weight will be considered psychotropic and will be subject to the control measures.”” EIHA also stated.

“This draft Royal Decree establishes the conditions for the prescription, preparation, dispensing, and use of standardised master formulas for cannabis preparations. Likewise, it establishes a register for standardised cannabis preparations used in the elaboration of these master formulas, in order to guarantee their quality.” the official language of the Royal Decree states (translated from Spanish to English).

“In the preparation of this draft, the different normative regulations on the regulation of medical cannabis in countries of the European Union (France, the Netherlands, the Czech Republic, Croatia, Portugal, Italy, Germany…) and in third countries (Switzerland, Israel, the United Kingdom, Canada…) have been considered. The review has been carried out considering its scientific basis, based on evidence published in scientific literature, the available information on the functioning of the different systems and their health effects, and the possibility its adaptation to the Spanish regulatory framework.” the Decree also states.

Despite the lack of proper regulations in Spain, the nation’s cannabis industry is thriving, albeit not within a regulated system. Suffering patients deserve to have safe access to safe medical cannabis therapies, and entrepreneurs and investors deserve to operate in a business environment that is built on a strong foundation of certainty.

italy flag italy flag italy flag

European Parliament Accepts Low-THC Cannabis Petition

Written by Hazel Norman on . Posted in Business, Policy.

Cannabis products that are low in THC are very popular in many parts of the world right now, particularly in Europe. ‘Cannabis light,’ as it is sometimes referred to, is widespread across the European continent.

Italy is a market where cannabis light products are very popular, however, the products have been the target of recent crackdown attempts by Italian lawmakers and regulators. Attempts to ban Italy’s cannabis light industry resulted in a petition being previously submitted to the European Parliament, and the petition was recently accepted.

“The petition presented by several national acronyms last September was accepted by the Petitions Committee (PETI) of the European Parliament. Its chairman, Polish conservative Bogdan Rzońca, asked the European Commission to “conduct a preliminary investigation into the issue.” reported EUNews in its recent coverage.

“In the response addressed to the president of Canapa Sativa Italia, Mattia Cusani (the first signatory of the petition that gathered the yes of Confagricoltura, Cia, Copagri, Cna Agroalimentare, Unci, Liberi Agricoltori, Altragricoltura, Associazione Florovivaisti Italiani, Federcanapa, Sardinia Cannabis, Assocanapa, Resilienza Italia Onlus, Canapa delle Marche, the European Industrial Hemp Association -EIHA, and the French UPCBD) the PETI committee pointed out that the Court of Justice of the European Union, in a judgement of October 4, 2024, ruled that Member States may not impose restrictions on the cultivation of industrial hemp, including indoor cultivation and cultivation exclusively for the production of inflorescences, unless such restrictions are supported by factual scientific evidence relating to the protection of public health.” the outlet also reported.

The battle over cannabis light in Italy and other parts of Europe comes at a time when many European countries are working to modernize their cannabis policies. Most European nations now have some type of medical cannabis program operating to some degree.

Currently, cannabis that is not low in THC is expressly legal for adult use in Malta, Luxembourg, and Germany. Additionally, regional adult-use cannabis commerce pilot trials are operating in the Netherlands and Switzerland.

gavel law courtroom judge jury conviction appeal gavel law courtroom judge jury conviction appeal gavel law courtroom judge jury conviction appeal

Hemp Flowers Are Now Subject To Austria’s Tobacco Tax

Written by Hazel Norman on . Posted in Business, Policy.

The level of popularity for hemp flowers among cannabis consumers has exploded in recent years, particularly in Europe. ‘Cannabis light,’ as it is sometimes referred to, contains low enough levels of THC that many markets in Europe permit sales of it.

Whereas adult-use cannabis commerce for products derived from non-hemp sources remains illegal throughout most of Europe, commerce involving hemp products is often legal to some degree. Hemp flowers are a bit of a grey area from a regulatory standpoint in much of Europe. In Austria, a recent court decision declared that hemp flowers are subject to the nation’s tobacco tax.

“The Austrian Administrative Court (VwGH) has recently ruled that dried hemp flowers with a THC content of up to 0.3% are subject to tobacco tax.” reported Cannabis Industrie in its original coverage. “In addition to the tax liability, these products are also subject to the Tobacco Monopoly Act, which means that they may only be sold through tobacco shops.”

“The decision of the VwGH could have far-reaching consequences for the cannabis industry in Austria. Producers and distributors must now adapt to the new regulations and comply with the sales restrictions. This could lead to a shift in the market and possibly new legal challenges.” the outlet also reported.

According to analysts at the Tax Foundation, Austria places a €3.32 excise duty per 20-pack of tobacco cigarettes. An additional ‘value added tax’ or VAT is also placed on tobacco products, raising the total tax per pack of tobacco cigarettes to €4.23. The Tax Foundation estimates that tax as a share of the final selling price per pack of tobacco cigarettes is 77%.

Regulators across Europe, and many other parts of the world, are struggling to rectify the inconsistencies in laws and regulations pertaining to consumable hemp products. For many years, hemp products were largely limited to textiles. However, many savvy entrepreneurs are bringing more consumable hemp products to emerging markets, and policymakers are scrambling to try to catch up.

cannabis concentrate concentrates dabs rosin resin hash hashish cannabis concentrate concentrates dabs rosin resin hash hashish

Malta Cannabis Associations Permitted To Sell Concentrates Later This Year

Written by Hazel Norman on . Posted in Business, Policy.

Malta will forever hold the distinction of being the first European nation to adopt a national recreational cannabis legalization measure. Lawmakers in Malta approved adult-use legalization in 2021, permitting adults to cultivate, possess, and consume cannabis.

Before Malta approved legalization, the only other nations to do so previously were Uruguay in 2013 and Canada in 2018. A major component of Malta’s legalization model is permitting cultivation associations, sometimes referred to as clubs. Members can source cannabis legally through the associations.

So far, cultivation associations in Malta have only sold cannabis flower. However, starting later this year cannabis cultivation associations in Malta will also be able to sell certain concentrated cannabis products to their members.

“Malta’s cannabis associations will be allowed to sell cannabis resin and rosin, the Authority for the Responsible Use of Cannabis (ARUC) Executive Chairperson Joey Reno Vella confirmed to MaltaToday.” reported MaltaToday in its local coverage.

“ARUC is in the process of updating its Directives to permit the distribution of cannabis resin (hash) and similar processed products, such as rosin, through licensed CHRAs. However, it is imperative to highlight that only solvent-free, non-chemical extraction processes will be authorised. The use of solvents and/or chemical agents for the production of cannabis derivatives remains strictly prohibited. Additionally, the conversion of cannabis into oils and tinctures will not be permitted under these amendments,” Joey Reno Vella said according to the media outlet.

Cannabis concentrates, sometimes referred to as cannabis extracts, are very popular among adult cannabis consumers and medical cannabis patients. According to Coherent Market Insights, the global cannabis extract market “is expected to reach USD 38.13 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 17.4% from 2024 to 2031.”

In other recent cannabis news out of Malta, the Authority for the Responsible Use of Cannabis signed an agreement with the University of Malta to conduct cannabis-based research.

“The authority and the university’s chemistry department plan to study pesticides and “substances” found in legal and illegal cannabis by next October, with legal samples from cannabis associations and illegal samples held by the courts due to be tested.” reported Times of Malta.

“The tests aim to scientifically demonstrate how the dangers of controlled – legally grown – cannabis and illegal offerings vary, Reforms Junior Minister Rebecca Buttigieg said.” the local media outlet also reported.

cannabis plant leaves cannabis plant leaves

German Pharmacists Oppose Reclassifying Cannabis As A Narcotic Drug

Written by Johnny Green on . Posted in Business, Policy.

German pharmacist Florian Sedlmeier and other members of Germany’s pharmacy industry are publicly pushing back on an effort by cannabis opponents in Germany to reclassify cannabis as a narcotic drug in the European nation. Cannabis was removed from Germany’s Narcotics List last year as part of the enactment of the CanG law.

“Pharmacist Florian Sedlmeier warns against reclassifying medicinal cannabis as a narcotic drug (BtM). Such a step would increase the bureaucratic burden and make it more difficult to provide patients with rapid care, ” stated the German Cannabis Business Association (BvCW) in its recent newsletter, citing an article from apotheke-adhoc. “He considers the concern expressed by SPD Health Minister Clemens Hoch that medicinal cannabis can be ordered too easily online to be understandable, but stresses that pharmacies carefully check prescriptions and licenses.”

“Reclassification as a narcotic would not curb the black market, but rather limit storage and the range of products available in pharmacies. Pharmacies are currently benefiting from the fact that medicinal cannabis no longer has to be stored in safes and can be prescribed more easily using e-prescriptions or model 16 forms. Instead of returning to the narcotic prescription requirement, Sedlmeier proposes stricter control of medical prescriptions, for example by requiring doctors to submit prescriptions and possible sanctions in the event of misuse.” BvCW also reported.

Germany implemented the first provisions of its new adult-use cannabis legalization law on April 1st, 2024, legalizing the personal cultivation, possession, and consumption of cannabis by adults. Another major component of the first provisions involved the previously referenced removal of cannabis from the nation’s Narcotics List.

According to a recent report by the Bloomwell Group, prescriptions for medical cannabis in Germany increased by roughly 1,000% between March 2024 and December 2024. The report also found that prices for medical cannabis products are decreasing in Europe’s largest medical cannabis market.

Another component of Germany’s new legalization model involves permitting cultivation associations. The application process for cultivation associations started on July 1st, 2024, and to date, 83 cultivation applications have been approved, with hundreds more working their way through the process.

Germany was already home to the largest legal medical cannabis industry in Europe before the enactment of adult-use legalization, and changes in medical cannabis policies and regulations in 2024 have resulted in a domestic medical cannabis boom, as demonstrated by the data in Bloomwell’s recent report.

Legal medical cannabis imports continue to rise in Germany as well. During the first three full months following Germany’s enactment of the CanG adult-use legalization law (Q3), legal medical cannabis imports increased by over 70% compared to the previous period.

Alex Rogers, founder and CEO of the International Cannabis Business Conference, recently visited Helios’ Munich pharmacy location to see their world-class operations firsthand, which can be viewed in the video embedded below. The video provides a great glimpse into Germany’s emerging legal medical cannabis industry:

cannabis plant cannabis plant

Ancillary Cannabis Industry Sectors Projected To Experience Major Growth

Written by Johnny Green on . Posted in Business.

When many people think of the emerging global cannabis industry, they tend to think about cultivating cannabis and selling cannabis. While those are obviously important components of the legal cannabis industry, they are only two sectors. The legal cannabis industry is much more complex and dynamic than just growing and selling cannabis and is made up of several other sectors, all of which have their own opportunities and market potential. Below are some notable examples that entrepreneurs, investors, and innovators should consider.

Cannabis Technology

Nearly every sector of the cannabis industry, including the cultivation and retail sectors, incorporates technology in one way or another. The ancillary cannabis technology sector comprises several subsectors, some of which are listed later in this article. It is arguably the most needed and promising ancillary sector of the emerging legal cannabis industry, and entrepreneurs, investors, and innovators are wise to explore the various opportunities. According to a recent market analysis by Coherent Market Insights, the “cannabis technology market is estimated to be valued at USD 4.10 Bn in 2024 and is expected to reach USD 20.01 Bn by 2031, exhibiting a CAGR of 25.4% by 2031.”

Consumption Devices

One constant in every legal cannabis market is that people will be consuming cannabis, and how they consume cannabis is evolving at a seemingly ever-increasing rate. While some consumers and patients continue to smoke cannabis via more rudimentary methods like joints and pipes, many are using more advanced consumption methods, such as portable vaporizers. The global portable vaporizer sector is already huge and getting bigger with every passing year. According to analysts at The Business Research Company, the portable vaporizer market is “projected to grow from $2.56 billion in 2023 to $2.90 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%,” and is “expected to reach $4.82 billion by 2028.”

Product Testing

A standard component of every market where legal cannabis commerce is permitted is that legal products have to be tested for compliance. Cannabis testing helps consumers and patients know that the products they are consuming are safe and informs them about important information regarding the product’s contents, such as cannabinoid levels. Technavio recently estimated that the size of the global cannabis testing sector will “grow by USD 2.05 billion from 2024-2028.” The Business Research Company has also recently published a projection, estimating that the sector will reach “$6.05 billion in 2028,” and analysts with Research and Markets project a global market value of $12.37 billion by 2035.

Packaging

Cannabis product packaging is another ancillary sector that shows a lot of promise, with most legal cannabis products being stored and dispersed in some kind of required packaging. That presents significant opportunities for companies that specialize in creating effective product packaging options. As more markets become legal across the globe, the demand for cannabis packaging will increase. According to a recent cannabis packaging sector projection by Coherent Market Insights, the “global cannabis packaging market is expected to reach US$ 13.17 billion by 2030, from US$ 2.64 billion in 2023, at a CAGR of 25.8% during the forecast period.”

Food And Beverages

Just as patients and consumers are increasing their use of advanced portable vaporizer technologies, they are also using other smokeless forms of cannabis consumption, most notably foods and beverages. Edibles and liquid consumables are increasing in popularity in markets where they are permitted, and that is reflected in recent market projections. For example, analysts at Allied Analytics estimate that the global cannabis food and beverage market size “was valued at $427.0 million in 2018, and is expected to reach $2,632.0 million by 2026, registering a CAGR of 26.6% from 2019 to 2026.” The food and beverage sector is not limited to intoxicating products. Future Market Insights projects that the global hemp protein powder market alone will be worth over $1 billion by 2035.

Insurance

Business insurance is something that many companies need, and entities in the cannabis industry are no exception. Business insurance helps mitigate the unexpected costs that may arise as a company conducts its day-to-day operations. Insurance in the cannabis industry is not as established as it is in other legal industries. However, more insurance professionals are either working with cannabis companies now or are considering doing so compared to past years. One recent market projection for the emerging cannabis insurance sector estimates that the cannabis insurance market is expected to grow to “USD 6.7 billion by 2032” with a CAGR of “around 14.14% during the forecast period (2025 – 2032).”

paraguay flag paraguay flag

Paraguay Exports Cannabis Flower To Switzerland In Historic First

Written by Hazel Norman on . Posted in Business.

Paraguay first adopted a national industrial hemp legalization measure back in 2019, and the South American nation recently passed a historic milestone by making its first legal export of cannabis flowers to Switzerland.

“The Paraguayan Chamber of Industrial Cannabis proudly announced the first export of 100% Paraguayan industrial cannabis flowers, known as Kuñatai, to Switzerland. This flower, registered with specific cultivars, stands out for its high quality and purity, meeting the rigorous standards required by the Swiss market and opening doors for expansion to other destinations in Europe.” reported Sechat in its local coverage (translated from Portuguese to English).

“The export of Kuñatai to Switzerland represents a significant step forward for Paraguay on its path to internationalizing its cannabis industry.” the outlet also stated.

Paraguay’s international cannabis industry pursuits come at a time when nearly six dozen nations around the world have adopted medical cannabis legalization measures, many of which now import and export medical cannabis products.

Additionally, Uruguay, Canada, Malta, Luxembourg, Germany, and South Africa have adopted adult-use cannabis legalization measures, although none of those countries currently permit the importation of recreational cannabis products and all adult-use cannabis is produced domestically either by individuals for personal use or by local companies.

Regional adult-use cannabis commerce pilot trials are also currently operating in the Netherlands and Switzerland. Pilot trials are also expected to launch in Germany soon. Two dozen states in the United States have adopted recreational cannabis legalization measures, although cannabis remains prohibited at the federal level in the U.S.

Analysts at Research and Markets estimate that “the global cannabis cultivation market was valued at USD 43.52 billion in 2023 and is anticipated to record steady growth over the forecast period, with a CAGR of 5.25% through 2029.”

hemp-cannabis-flower-plant-garden-outdoor hemp-cannabis-flower-plant-garden-outdoor hemp-cannabis-flower-plant-garden-outdoor

Himachal Pradesh Cabinet Approves Hemp Pilot

Written by Hazel Norman on . Posted in Business, Policy.

The government in Himachal Pradesh, a state in India, has approved a pilot study to examine the potential benefits of permitting industrial hemp cultivation and the creation of related medical products and scientific research.

“The Himachal Pradesh cabinet has approved the report of a committee recommending the controlled cultivation of cannabis for industrial, scientific, and medicinal purposes, setting the stage for its legalisation in the state. The report, previously passed by the Himachal Vidhan Sabha, was prepared with inputs from opposition BJP members, horticulture experts, and scientists.” Indian Express stated in its local coverage.

“Controlled cannabis cultivation will be undertaken jointly by two agricultural universities—Chaudhary Sarwan Kumar Krishi Vishvavidyalaya, Palampur, and Dr YS Parmar University of Horticulture, Nauni, Solan. The Agriculture Department has been designated as the nodal body for the initiative.” the outlet also reported.

A recent market analysis by Knowledge Sourcing Intelligence estimates that the global industrial hemp market “is forecasted to grow at a CAGR of 17.75% between US$9.913 billion in 2025 to US$22.438 billion in 2030.”

A separate market analysis recently published by Markets and Markets predicts an even larger global industrial hemp market in the future, estimating that “the industrial hemp market is estimated at USD 11.03 billion in 2024 and is projected to reach USD 30.24 billion by 2029, at a CAGR of 22.4% from 2024 to 2029.”

The booming industrial hemp market is not limited to just industrial applications and medical products. According to analysts at Maximize Market Research, “the global hemp-infused beverage market is experiencing significant expansion, driven by increasing consumer awareness of hemp’s health benefits and a growing demand for functional, wellness-oriented drinks.”

“In 2023, the market was valued at USD 3.63 billion and is projected to grow at a compound annual growth rate (CAGR) of 28.9% from 2024 to 2030.” the analysts predict.

emergency room hospital bed beds emergency room hospital bed beds

Legal Retail Cannabis Isn’t Associated With Rise In Emergency Department Visits

Written by Frank Schuler on . Posted in Business, Science.

Canada was not the first country to adopt a national adult-use cannabis legalization measure. That distinct title goes to Uruguay, which legalized recreational cannabis in 2013, five years before Canada did so. However, Canada was the first G-7 nation to legalize recreational cannabis and remains the largest legal adult-use cannabis commerce experiment on earth.

According to a recent market analysis by Research and Markets, revenue generated by Canada’s legal cannabis cultivators “has ballooned at a CAGR of 43.4% to reach $13.1 billion over the past five years.”

Canadian cannabis companies dominate the legal global cannabis industry, an industry that analysts at The Business Research Company estimate was worth “$21.79 billion in 2023” and “$26.56 billion in 2024” and is projected to grow to an estimated “$58.93 billion by 2028 at a CAGR of 22.0%.”

Researchers at Allied Analytics offer up even rosier estimates and projections, finding that the legal cannabis market “was valued at $25.7 billion in 2021, and is estimated to reach $148.9 billion by 2031, growing at a CAGR of 20.1% from 2022 to 2031.”

A common claim made by cannabis opponents who try to thwart the growth of the emerging legal cannabis industry hinges on ’emergency room visits spiking due to cannabis legalization.’ The results of a recent study conducted in Canada throw cold water on those claims. Below is more information about the study and its findings via a news release from NORML:

Toronto, Ontario: The establishment of licensed cannabis retailers is not associated with any uptick in marijuana-related emergency department (ED) visits, according to longitudinal data published in the International Journal of Drug Policy.

A team of Canadian researchers assessed the impact of cannabis store openings on ED visits in 278 communities in Ontario.

They found “no evidence that the allocation of cannabis retailer licenses led to changes in cannabis-related ED visits.”

Similarly, no changes in ED visits related to either alcohol use or opioids were identified.

“Despite the anticipation that the introduction of licensed cannabis retailers might influence such health outcomes, our findings suggest no significant changes in ED visit rates following the allocation of retail licenses,” the study’s authors concluded. “This research highlights the complex relationship between the availability of cannabis retail options and public health metrics. … Given these findings, policymakers may consider focusing on understanding regional factors (e.g. cannabis pricing and retailer hours of operation) beyond retail density that could influence substance-related health outcomes.”

Other studies have failed to identify any association between dispensary openings and rising local crime rates. Studies have documented a relationship between dispensary openings, rising home values, and reductions in opioid-related mortality.

Full text of the study, “The impact of recreational cannabis retailer allocation on emergency department visits: A. natural experiment utilizing lottery design,” appears in the International Journal of Drug Policy. Additional information is available from the NORML Fact Sheet, ‘Societal Impacts of Cannabis Dispensaries/Retailers.’

icbc germany patients rise 1000 percent icbc germany patients rise 1000 percent

Report: German Medical Cannabis Prescriptions Increased 1,000% In 9 Months

Written by Johnny Green on . Posted in Business.

According to a recent report by the Bloomwell Group, prescriptions for medical cannabis in Germany increased by roughly 1,000% between March 2024 and December 2024. The report also found that prices for medical cannabis products are decreasing in Europe’s largest medical cannabis market.

“Despite the rapid increase in cannabis patients, companies, doctors and pharmacies have ensured a secure supply,” explained Niklas Kouparanis, co-founder and CEO of Bloomwell, according to reporting by apotheke-adhoc.

“We are at the very beginning of a new era,” emphasized Kouparanis. “It is now the task of the next federal government to shape the regulatory framework in such a way that jobs continue to be created, investors are given security and innovation is promoted so that patients continue to benefit from cost-effective access to therapy.”

Germany adopted the first provisions of its new adult-use cannabis legalization law on April 1st, 2024. The provisions involved permitting adults to cultivate, possess, and consume personal amounts of cannabis. Additionally, cannabis was removed from Germany’s Narcotics List. The latter provision has provided a major boost to Germany’s medical cannabis industry.

Another component of Germany’s new legalization model involves permitting cultivation associations. The application process for cultivation associations started on July 1st, 2024, and to date, 83 cultivation applications have been approved, with hundreds more working their way through the process.

Germany was already home to the largest legal medical cannabis industry in Europe before the enactment of adult-use legalization, and changes in medical cannabis policies and regulations in 2024 have resulted in a domestic medical cannabis boom, as demonstrated by the data in Bloomwell’s recent report.

Legal medical cannabis imports continue to rise in Germany as well. During the first three full months following Germany’s enactment of the CanG adult-use legalization law (Q3), legal medical cannabis imports increased by over 70% compared to the previous period.

Alex Rogers, founder and CEO of the International Cannabis Business Conference, recently visited Helios’ Munich pharmacy location to see their world-class operations firsthand, which can be viewed in the video embedded below. The video provides a great glimpse into Germany’s emerging legal medical cannabis industry:

doctor medical hospital clinic doctor medical hospital clinic doctor medical hospital clinic

Czech Doctors Prescribed 318.7 Kilograms Of Medicinal Cannabis In 2024

Written by Johnny Green on . Posted in Business, Policy.

According to data from Czechia’s State Institute for Drug Control and as reported locally by BRNO Daily, doctors in the Czech Republic prescribed 318.7 kilograms of medicinal cannabis in 2024 to an average of roughly 3,300 patients per month. Those figures are set to expand in April 2025 when Czech GPs will be permitted to prescribe cannabis for chronic pain.

“GPs will now be able to prescribe medicinal cannabis for chronic pain, and patients can also be prescribed up to a three-month dose per prescription, according to changes to the relevant legislation which will come into force in April this year.” BRNO Daily stated in its reporting.

For context, in 2023 Czech doctors prescribed 258.8 kilograms of medical cannabis, 157.4 kilograms in 2022, and 109.4 kilograms in 2021. Additionally, the Czech Republic’s legal medical cannabis industry served an average of 2,570 patients in 2023, in 2022 it was 1,886, and in 2021 it was 1,389.

The Czech Republic’s medical cannabis expansion occurring later this year comes amidst a push for wider cannabis policy reform in the European nation. In November 2024, the Czech Republic’s cabinet approved a plan that would permit adults to cultivate multiple plants in their private residences and possess a personal amount of cannabis.

The plan, which would legalize the cultivation of up to three cannabis plants and set a maximum possession limit of 50 grams of cannabis, was originally introduced by the Czech Republic’s Ministry of Justice back in September 2024. The plan does not go far enough according to members of the Czech Pirate Party.

“Instead of legalization and money in the budget, today the government presents pasquil. You can grow cannabis, but you can’t harvest it. To be able to grow three cannabis plants and at the same time have a limit of 50 grams that you can have at home is absurd. It’s like you could raise three hens, but they could lay a maximum of one egg, otherwise you’ll be fined or go to jail,” said former Deputy Prime Minister and former head of the Pirates Ivan Bartoš according to previous reporting by Echo24.

Cannabis advocates in Czechia are urging lawmakers to modernize the nation’s cannabis policies in a more comprehensive fashion. More information about their proposal can be found at: www.racionalniregulace.cz.

Starting in July of this year, the Czech Republic will regulate sales of cannabis containing up to one percent THC. The public policy change will also involve permitting regulated sales of kratom.

“The regulation focuses on substances deemed to pose low public health and social risks based on current scientific evidence. These include Kratom and kratom extracts, known for their stimulant and pain-relieving effects; cannabis with up to 1 percent THC, a low-potency form of cannabis with minimal psychoactive effects.” reported Expats CZ in its local coverage.

“Cannabis extracts and tinctures with up to 1 percent THC are also included.” Expats CZ also reported. Low-THC cannabis products will be permitted to be sold in licensed stores starting this summer in Czechia, although certain forms of commerce such as automated vending machines will remain prohibited.

spain flag spain flag

Spain Is Expected To Approve A Medical Cannabis Measure Soon

Written by Johnny Green on . Posted in Business, Policy.

Lawmakers in Spain are reportedly on track to approve a medical cannabis industry regulation measure before this summer. Spain has long been home to a thriving medical cannabis community and market, however, regulations for the nation’s domestic medical cannabis industry have proved to be elusive for years.

The effort to bring Spain’s medical cannabis policies into the modern age passed a major milestone back in October 2024 when the nation’s Ministry of Health published a draft royal decree focused on medical cannabis. That draft royal decree appears to be moving further along in the process.

“After years of waiting, Spain seems to be finally on its way to regulating medical cannabis. If all goes according to plan, the Royal Decree regulating the use of cannabis for medical purposes could be approved before the summer of 2025.” InSpanje stated in its reporting.

“The Spanish Ministry of Health has sent a draft of the Royal Decree to the European Commission, as required by European regulations. Brussels has three months to respond to the proposal. Once a positive response is received, the Council of State will give its opinion and the government can approve the decree. In total, this process could take up to five months.” the outlet also reported.

“The draft establishes broad restrictions on the medical use of cannabis and specifies very specifically the pathologies for which it can be used: multiple sclerosis (stiffness and muscle spasms associated with the condition); severe forms of refractory epilepsy (certain types of epilepsy that do not respond to conventional treatments); nausea and vomiting caused by chemotherapy; and refractory chronic pain (persistent pain that is not relieved by the usual treatments). In all these cases, experts believe that there is “scientific evidence” of the benefits of medical cannabis.” reported Sur late last year in its domestic coverage.

“The Ministry addresses this regulation based on the conclusions of the Subcommittee of the Congress of Deputies for the analysis of experiences with the regulation of cannabis for medicinal use, which called on the Spanish Agency for Medicines and Health Products to prepare a roadmap to approve the regulation.” Spain’s government stated in a press release about the measure (translated from Spanish to English) late last year.

“The proposed regulation guarantees the quality of the products and the safety of patients, enabling the legal avenues available to have therapeutic compounds based on standardized cannabis preparations that have shown evidence in relieving pain and the suffering of patients, considering the oral administration of these compounds as it is the most appropriate in terms of therapeutic effectiveness and safety for patients.” the government’s press release stated.

“This regulation is designed to evolve dynamically, allowing new elements to be incorporated as more information and the experience of the therapeutic cannabis program becomes available. In addition, it will contribute to generating more and better evidence on the use of cannabinoids for therapeutic purposes.” Spain’s government also stated.

Despite the lack of proper regulations in Spain, the nation’s cannabis industry is thriving, albeit not within a regulated system. Suffering patients deserve to have safe access to safe medical cannabis therapies, and entrepreneurs and investors deserve to operate in a business environment that is built on a strong foundation of certainty.

nurse doctor hospital stethoscope nurse doctor hospital stethoscope nurse doctor hospital stethoscope

37% Of Medical Cannabis Patients In New Zealand Have A Prescription

Written by Hazel Norman on . Posted in Business, Policy.

Modern medical cannabis was first legalized in New Zealand in 2018, with the Medicinal Cannabis Scheme launching in 2020. Since that time, a growing number of medical cannabis patients have received prescriptions to safely access medical cannabis products.

“In 2022/23, fewer than one in 10 medical users obtained a prescription for their cannabis. That had climbed to 37% in 2024, according to the annual New Zealand Drug Trends Survey (NZDTS) conducted by the Shore and Whariki Research Centre at Massey University’s College of Health.” states Cannabiz in its original reporting.

“Of 1,742 respondents who claimed all or most of their cannabis use was for medical purposes, 60% said they had not approached a health professional, down from 85% in 2022/23 and 93% in 2020, when the Medicinal Cannabis Scheme launched in New Zealand.” the outlet also reported.

Initially, all legal medical cannabis products sold in New Zealand were imported. However, in September 2022, New Zealand’s government granted permission for domestic medical cannabis cultivation.

Voters in New Zealand decided on a recreational cannabis legalization measure in 2020, with the measure being narrowly defeated on Election Day. At the time, only two countries had adopted adult-use legalization measures – Uruguay and Canada.

Since the failed legalization vote in New Zealand, Malta, Luxembourg, Germany, and South Africa have approved national legalization measures. Additionally, nearly five dozen countries have now adopted medical cannabis legalization measures.

A recent survey of more than 23,000 New Zealanders found that 60% of respondents reported that they consumed less alcohol after beginning cannabis use. The survey also found that of people who report using cannabis and other substances, 60% of respondents reported consuming less synthetic cannabinoids, 44% reported using less morphine, and 40% reported using less methamphetamine.

germany flag germany flag germany flag

83 Cannabis Cultivation Associations Have Been Approved In Germany So Far

Written by Johnny Green on . Posted in Business, Policy.

Germany implemented the first provisions of its new adult-use cannabis legalization model on April 1st, 2024. The initial provisions involved permitting adults to cultivate, possess, and consume personal amounts of cannabis, among other things.

Then, starting on July 1st, 2024, people could start applying to launch a cultivation association in Germany. Cultivation associations, sometimes referred to as cannabis clubs, involve members joining an association from which to legally source their recreational cannabis. Personal provisions and cultivation associations serve as ‘Pillar 1’ of Germany’s legalization model.

According to a recent response from the federal government to an inquiry made by the Left Party in Germany, and as initially reported locally by Frankfurter Rundchau, 83 cannabis club applications were approved nationwide in Germany as of December 2024. An additional 349 applications are being processed, and 12 applications have been rejected so far.

“There are currently no cannabis clubs in either Saarland or Bavaria. Applications have been submitted, in Bavaria, for example, there are 29, but those interested will have to be patient.” Frankfurter Rundchau stated in its reporting. “The CSU-led Bavarian state government has already announced that it will take its time with the approval.”

Currently, cannabis is legal for adult use in Uruguay, Canada, Malta, Luxembourg, Germany, and South Africa. Of those, Uruguay and Malta expressly allow cultivation associations (or ‘clubs’) as part of their legalization models. For contextual purposes, Uruguay currently has 460 registered associations/clubs, and Malta had only three registered cannabis clubs as of last year.

When comparing the populations of Uruguay (roughly 3.4 million) and Malta (roughly 550,000) to that of Germany (over 84 million), it is obvious that Germany needs more cultivation associations to support its adult cannabis consumer base.

However, it is also worth pointing out that Uruguay legalized cannabis in 2013, and Malta in 2021, so both countries have had a significant headstart over Germany when it comes to cultivation association/club implementation.

euros money currency euros money currency euros money currency euros money currency euros money currency euros money currency

Cannabis Can Be An Economic Growth Driver In Germany

Written by Johnny Green on . Posted in Business, Policy.

If properly regulated and allowed to reach its full potential, Germany’s emerging cannabis industry can serve as an economic growth driver, and lawmakers elected in Germany’s upcoming election need to recognize that. That is the premise of a new position paper recently published by the German Cannabis Business Association (BvCW).

The position paper, titled (translated from German to English) ‘Cannabis as a growth driver: Industrial opportunities and policy directions,’ defines three core positions for Germany’s upcoming federal election to be held next month:

  1. Combating organized crime, increasing public safety – enabling commercial supply chains for consumer cannabis.
  2. Complete the liberalization of industrial hemp in order to leverage economic and ecological potential.
  3. Working together to create modern regulations for telemedicine.

“The cannabis industry in Germany has developed into a dynamic and promising industrial sector since the legalization of medical cannabis in 2017. For the medical cannabis sector alone, sales of around 450 million euros are forecast for last year – and the trend is continuing to rise.” BvCW stated in its newsletter this week.

“With the introduction of the Cannabis Act, the market for home cultivation equipment for recreational cannabis has also grown significantly. Industrial hemp also offers diverse and sustainable potential for agriculture, the construction industry, textiles and composites.” the newsletter also stated.

“The cannabis industry is a magnet for foreign investment capital, which creates jobs and generates taxes. The Cannabis Act was an important building block on which politics should continue to build,” explains Dirk Heitepriem, President of BvCW.

“The cannabis industry is growing and has much more potential. In order to exploit this, it is important that the next federal government finally abolishes the intoxication clause for industrial hemp and supports the approval of model projects with professional supply chains,” adds Michael Greif, Managing Director of BvCW.

Germany implemented the first provisions of its new adult-use cannabis legalization model back on April 1, 2024. Regulators then launched the application process for cultivation associations on July 1, 2024. The launch of regional adult-use cannabis commerce pilot trials was initially expected by the end of last year, however, the launch of trials has experienced various delays due to politics.

“While the public debate often remains limited to the area of ​​consumer cannabis, it is primarily the medical cannabis and industrial hemp segments that have developed into an important industrial sector.” BvCW stated in its position paper regarding Germany’s emerging cannabis industry.

“Especially against the background of international legalization projects for medical and, in some cases, consumer cannabis and a weakening German economy, it is crucial to understand this development not only as part of health policy but also as a natural part of future-oriented economic policy.” BvCW also stated in the position paper.

Currently, cannabis is legal for adult use in Uruguay, Canada, Malta, Luxembourg, Germany, and South Africa. Recreational pilot trials are also operating in the Netherlands and Switzerland, and two dozen states in the U.S. have adopted adult-use legalization measures.

With the looming election in Germany on the horizon, and a seemingly shifting political landscape, some cannabis industry members and reform advocates are expressing concern that Germany’s eventual new government may hinder the momentum that Germany’s cannabis movement has experienced in recent years.

“Despite the complete ban on cannabis in recent decades and intensive law enforcement on both the supply and demand sides, cannabis consumption has continued to rise,” BvCW points out in its position paper. “In order to push back the black market with all its negative implications, legal and regulated access routes to quality-assured cannabis products are necessary.”

“This would not only result in a reduction in the burden on law enforcement authorities, more security for consumers and better protection of minors, but also offer the opportunity to benefit from the economic potential in the form of corporate and sales taxes.” states BvCW.

“The Cannabis Industry Association would like to work together with a new federal government to further develop cannabis regulation. Starting with strengthening the resilience of domestic pharmaceutical supply chains, from competitive conditions for agriculture to closely monitored supply chains for consumer cannabis: this is the only way to enable state control and effectively strengthen internal security.” the position paper stated.

BvCW advocates for regulating, and not prohibiting, several sectors of Germany’s emerging cannabis industry in its position paper, from cannabis seeds and genetics to telemedicine and the launch of pilot trials. You can read the full position paper at this link here.

Cannabis flower bud prerolls joints Cannabis flower bud prerolls joints Cannabis flower bud prerolls joints

Rate Of Legal Cannabis Buyers Continues To Increase In Uruguay

Written by Hazel Norman on . Posted in Business, Policy.

Uruguay became the first nation on earth to adopt a national adult-use cannabis legalization law back in 2013. The first legal recreational sales were launched in registered pharmacies in Uruguay in 2017. Since that time, the number of adults making legal purchases in Uruguay has increased considerably.

“The number of legal marijuana buyers rose to some 102,156 people over the course of last year, boosted by the market debut of the Epsilon variant, which has a higher THC content (20%), and was in high demand.” reported Ambito.

“The new, more potent variant debuted in October, and in the following two months alone, a total of 359 kilos were sold in pharmacies, more than what had been sold up to that point of Alpha or Beta, according to data provided by the Institute for the Regulation and Control of Cannabis (IRCCA).” the media outlet also reported in its local coverage.

When legal sales at pharmacies began in Uruguay in the summer of 2017, consumers could initially choose from two different strains. The two strains are named ‘Alpha’ and ‘Beta’, each with tetrahydrocannabinol (THC) levels equal to or less than 9%, and cannabidiol (CBD) levels equal to or less than 3%.

Then, in 2022, Uruguay permitted a third option, ‘Gamma,’ which has a THC level of equal to or less than 15%, and CBD levels of equal to or less than 1%. Regulators in Uruguay then approved a fourth option that contains a higher level of THC than the other three options.

“The new variant has a tetrahydrocannabinol (THC) content of equal to or less than 20% and a cannabidiol (CBD) content of equal to or less than 1%.” stated Latin America Reports in its local coverage at the time of the strain’s launch.

Currently, 74,583 adult consumers are reportedly registered to make legal recreational cannabis purchases from Uruguay’s 40 authorized pharmacies making sales. Additionally, a reported 15,796 adults are members of 460 cannabis clubs registered in Uruguay, and another 11,597 adults reportedly cultivate legal plants in their homes.

Uruguay’s legal cannabis companies exported over $3 million worth of medical cannabis products in the last year to such nations as Germany, Portugal, Australia, New Zealand, and the United States. Uruguay’s export data is part of a report recently published by the Uruguay XXI Institute.

hightide logo hightide logo

High Tide Enters German Medical Cannabis Market Via Acquisition Of Purecan GmbH

Written by Johnny Green on . Posted in Business.

High Tide, a leading community-grown, retail-forward cannabis enterprise, has officially entered the medical cannabis market in Germany through a deal with Purcan GmbH. High Tide’s acquisition will give the company a majority stake in Purecan’s operations, German import license, warehousing and logistics infrastructure, and in-development telemedicine portal.

“High Tide intends to leverage its Canadian Licensed cannabis procurement expertise, built on over $1.5 billion of the Company’s cumulative cannabis sales since Canadian cannabis legalization, to build a significant, market-leading German medical cannabis business unit.” the company stated in a news release.

“With German medical cannabis sales increasing rapidly after the adoption of the Consumer Cannabis Act this past April, this acquisition provides a base for the Company to expand into other European medical cannabis markets in due course.” the company also stated.

Lawmakers in Germany adopted the first provisions of the nation’s new adult-use cannabis legalization model on April 1st, 2024, with cultivation association provisions launching in Germany on July 1st, 2024. Medical cannabis was first legalized in Germany in 2017.

“I am thrilled to announce that High Tide is taking a significant step towards becoming a truly global cannabis company. By acquiring a 51% stake in Purecan, including its European wholesale and import license, its fully built warehousing and logistics infrastructure, and in-development telemedicine platform, we are strategically positioned to leverage our robust networks and relationships with Canadian licensed producers. With almost half of all German medical cannabis imports coming from Canada, this acquisition paves the way for us to emerge as a leading supplier of medical cannabis from Canada into Germany, potentially replicating our market share success in Canada.” said Raj Grover, Founder and Chief Executive Officer of High Tide.

“As I’ve said before, our German strategy is multipronged. This highly accretive acquisition provides immediate market entry into Germany while we explore opportunities for consumer research in collaboration with the Food and Drug Agency, aligning with the ordinance recently signed by Germany’s Agriculture Minister,” he also said.

“In addition to capitalizing on Germany’s rapidly expanding medical cannabis market, the Purecan acquisition brings a company with strong cultural and operational alignment into the High Tide family. This alignment has been reinforced through months of in-depth collaboration and is reflected in Purecan’s impressive financials, high margins, and lean operations. We anticipate this business unit will deliver a healthy margin profile, further strengthening our existing Canadian and international business lines,” added Mr. Grover.

“Since our very first meeting with Raj and the High Tide team a few months ago, it became apparent to us that there were significant cultural and operational alignments between our companies. Given that demand for medical cannabis in Germany is currently outpacing supply, this merger provides Purecan with a unique opportunity to tap into High Tide’s unmatched procurement expertise and relationships with Canadian licensed producers who currently provide half of all medical cannabis imports into Germany. We look forward to a fruitful partnership between our two teams to create long-term value for all stakeholders involved,” said Dr. Ehsan Omari, Chief Medical Officer, Purecan GmbH.

cannabis plant flower cannabis plant flower cannabis plant flower

Czechia To Start Regulating Low-THC Cannabis This Year

Written by Johnny Green on . Posted in Business, Policy.

Starting in July of this year, the Czech Republic will regulate sales of cannabis containing up to one percent THC. The public policy change will also involve permitting regulated sales of kratom.

“The regulation focuses on substances deemed to pose low public health and social risks based on current scientific evidence. These include Kratom and kratom extracts, known for their stimulant and pain-relieving effects; cannabis with up to 1 percent THC, a low-potency form of cannabis with minimal psychoactive effects.” reported Expats CZ in its local coverage.

“Cannabis extracts and tinctures with up to 1 percent THC are also included.” Expats CZ also reported. Low-THC cannabis products will be permitted to be sold in licensed stores starting this summer in Czechia, although certain forms of commerce such as automated vending machines remain prohibited.

Additionally, starting on April 1, 2025, general practitioners (GPs) in the Czech Republic will be authorized to prescribe medical cannabis to suffering patients. The policy change is a result of a new decree from the nation’s Ministry of Health.

“The decree allows GPs to prescribe medicinal cannabis for chronic, intractable pain,” Ministry spokesperson Ondřej Jakob previously said according to local reporting by Prague Morning (translated from Czech to English).

Medical cannabis was first legalized in Czechia in 2013, however, only specialists can currently prescribe it resulting in roughly 8,000 patients receiving legal access. There is also a push in Czechia for wider adult-use cannabis legalization. However, that effort must clear various political hurdles before reaching the finish line and becoming law.

The Czech Republic’s cabinet approved a plan late last year that would permit adults in the European nation to cultivate multiple plants in their private residences and possess a personal amount of cannabis.

The plan, which would legalize the cultivation of up to three cannabis plants and set a maximum possession limit of 50 grams of cannabis, was originally introduced by the Czech Republic’s Ministry of Justice back in September 2024. The plan does not go far enough according to members of the Czech Pirate Party.

Cannabis advocates in Czechia are urging lawmakers to modernize the nation’s cannabis policies in a more comprehensive manner. More information about their proposal can be found at: www.racionalniregulace.cz.

Peter Homberg International Cannabis Business Conference Berlin 2023 Peter Homberg International Cannabis Business Conference Berlin 2023 Peter Homberg International Cannabis Business Conference Berlin 2023

Legal Cannabis Expert Peter Homberg Moves to gunnercooke

Written by Johnny Green on . Posted in Business, Policy, Science.

Renowned international cannabis policy and industry expert Peter Homberg recently announced that after 12 years at Dentons, he is joining international law firm gunnercooke.

“I’m excited to offer my clients truly exceptional service, leveraging gunnercooke’s flexibility, innovation, and collaborative culture to support them closely through their legal challenges, while also shaping and expanding my practice in a direction I’m passionate about.” Peter Homberg stated in a LinkedIn post over the weekend.

Mr. Homberg specializes in life sciences, IP and corporate law, and M&A transactions. Few people on the planet, if any, possess the extensive experience in advising on medical cannabis compliance as Peter Homberg.

gunnercooke is one of the fastest growing international law firms and has offices in the United States, Germany, CEE, Austria, Scotland, and England. The firm is a team of more than 500 professionals and has a client roster that includes Nike, Mercedes, Lidl, Santander and DHL.

Peter Homberg’s awards and recognitions are numerous, and rightfully so. Peter Homberg was already highlighted by Chambers Europe in 2014 as “a brilliant negotiator” who “has huge experience with biotech companies and is really goal driven.”

JUVE Handbook German Commercial Law Firms, mentioned Peter Homberg in 2015/2016 as a highly recommended practitioner. The international directory Best Lawyers ranked him among the best lawyers for Health Care Law and Pharmaceuticals Law in Germany. Global Law Experts (2015, 2016, 2017, 2018), Legal 100 (2021, 2022, 2023), and Leaders in Law (2020,2021) honored Peter Homberg as “Life Sciences Lawyer of the Year in Germany.”

He is a prolific speaker at cannabis industry and policy seminars and conferences, including being a long-time presenter at International Cannabis Business Conference events, and is the author of numerous articles and other publications on corporate and IP law in the areas of life sciences and medical cannabis.

Peter’s new position at gunnercooke will afford him more freedom and flexibility to focus on cannabis policy, industry, and education, as well as to further pursue his passion for life sciences. Medical cannabis and life sciences involve considerable overlap, but also have their own unique facets separate from each other.

I reached out to Peter Homberg this week to discuss his new endeavor and to pick his brain about what to expect in 2025 for German cannabis and the wider European cannabis industry.

“I am very excited about the recent career change.” Peter Homberg told me about his transition to gunnercooke. “I will be able to continue my work in the fields of cannabis and life sciences, and for cannabis specifically, I will be better suited to focus more on it as the industry continues to expand in Germany and in Europe.”

Peter Homberg is a tremendous resource and figure in the cannabis world, helping educate lawmakers and industry members from around the world about important cannabis matters. The significance of his advocacy is beyond measure in my opinion, and I was very happy to learn that not only will he continue his work in this area now that he is a part of gunnercooke, but he will also have more flexibility than ever to do so, including contributing more to Cannabis Law Journal.

“In my new position, I will continue to be an advocate for medical cannabis policy modernization and industry regulation, and for sensible adult-use cannabis reform.” Homberg stated to me in our discussion.

Homberg pointed out that prohibition does not bring humanity further along, and that it is a failed public policy that does not properly prioritize public health outcomes. He indicated that licensed and regulated cannabis shops are needed in Germany and throughout Europe to sufficiently combat the unregulated market.

“Pilot projects are the logical next step in Germany and in Europe and are needed as a steppingstone towards something more comprehensive. It is important that we gather the right data and use it to go to the European Commission to prove that wider regulated cannabis sales are the best way forward.” Homberg stated.

A topic that was prominent in our discussion was Germany’s Pillar 2 of its cannabis model, and with it, how the shifting political landscape in Germany will presumably be impacted by the upcoming election.

“I am confident that the upcoming election will yield a coalition government, and I am moderately optimistic that while recreational legalization’s progress will likely be slowed, it will not be completely reversed.” Homberg explained to me.

“A lot is still unclear. Many statements being made right now from cannabis opponents are being made in an ‘election mode’ and will not necessarily become reality. I expect extreme positions to level out after the election.” Homberg went on to say.

When I asked Peter Homberg to weigh in on what it will take for EU-level agreements to be modernised to permit wider recreational cannabis reform, he was very adamant that data gathering is key.

“Gathering more data from commerce pilot trials demonstrating that regulation works is vital to convincing the European Commission and skeptical member nations that regulation is better than prohibition. Probably 2-4 years’ worth of data from markets like Germany, Switzerland, the Netherlands, and others.” Peter Homberg explained.

“Medical cannabis is here to stay in Europe, and in my opinion, possesses the most potential for entrepreneurs and investors,” Homberg told me. “Medical cannabis has proven that it has its place in the pharmaceutical arena as time has gone on. There used to be a reluctance to accept that cannabis is medicine, however, it is now widely accepted that cannabis is medicine and truly helps suffering patients.”

“It is much more difficult to anticipate what will happen with the future of the recreational cannabis market due to several factors, both in Germany and throughout Europe. It will further develop, but at what rate and in which way is extremely difficult to predict.” Homberg said.

On behalf of the International Cannabis Business Conference team, I want to congratulate Peter Homberg on his new endeavor, and we look forward to what he does next in his career. You can see Peter Homberg present at upcoming International Cannabis Business Conference events and find out more about when and where he will appear at Internationalcbc.com.

dog pet cbd cannabidiol oil dog pet cbd cannabidiol oil dog pet cbd cannabidiol oil

Is Medical Cannabis For Animals The Next Big Thing?

Written by Johnny Green on . Posted in Business.

When most people think of medical cannabis, they think of how it pertains to suffering human patients, and rightfully so. Medical cannabis has helped countless human patients as a growing body of scientific research and patient testimonials demonstrates.

However, the benefits of medical cannabis are not limited only to humans. Many household pets and livestock can also benefit from the wellness properties contained within the cannabis plant and medical products derived from it.

More governments around the world are recognizing this fact and modernizing their cannabis policies and regulations to reflect it. For example, back in late 2019 Malta’s Minister for the Economy announced plans to permit the production of medical cannabis for veterinarian use.

Late last year, Brazil’s National Health Surveillance Agency decided to amend Ordinance SVS/MS 344/1998 to allow the regulation of medical cannabis products for animals by the Ministry of Agriculture and Livestock. Other examples of similar policy modernization can be found elsewhere around the globe.

Medical cannabis for animals is an underrated sector of the emerging legal cannabis industry and possesses tremendous profit potential for innovative entrepreneurs and savvy cannabis industry investors.

Industry analysts at Research and Markets recently projected that the CBD pet market size alone is expected to reach $1.72 billion by 2030 and increase at a compound annual growth rate of 32.47% between now and then. This of course does not take into account other cannabinoids and non-pet animals like farm livestock.

Researchers estimate that there are over 900 million pet dogs globally, and another 370 million pet cats. In the United States alone pet owners spend an estimated $136 billion on pet products annually. Add to the mix tens of billions of cattle, sheep, goats, chickens, pigs, and other livestock around the world, and the potential market for medical cannabis wellness products for animals is off the charts.

The medical cannabis for animals sector is very young and has hurdles to overcome to be sure, not the least of which is the need for more research. Determining which cannabinoids and in which specific doses for each animal type and size is no small feat.

With that being said, individuals and entities who can figure it out safely and reliably are sure to reap considerable financial rewards in the future. Medical cannabis for animals is virtually guaranteed to be the next big thing. It is not a question of if, but rather, a question of when.

hemp cord string fiber textiles hemp cord string fiber textiles

Textile Industry Members In India And South Korea Forge Hemp Partnerships

Written by Hazel Norman on . Posted in Business.

At a recent meeting hosted by the Wool and Woolens Export Promotion Council, members of the textile industries in both India and South Korea announced plans to, among other things, forge partnerships to tap into the industry potential of the industrial hemp fiber sector.

“Attendees discussed innovative ways to greater integrate hemp into India’s textile ecosystem, and the benefits of blending hemp with wool to create sustainable products that can help meet the rising global demand for eco-friendly materials.” reported Hemp Today in its original coverage.

“Also during the meeting, India’s Minister of Textiles, Giriraj Singh, reaffirmed his commitment to fostering the growth of commercial hemp production, pledging to collaborate with Uttarakhand Chief Minister Pushkar Dhami to draft a proposal aimed at aligning policies and promoting growth within the sector.” the outlet also reported.

Despite a long history with the hemp plant, India does not currently have national hemp industry regulations permitting such activity. However, some local jurisdictions have adopted industry rules and regulations, and India’s hemp industry should experience continued growth in the foreseeable future.

According to a recent market analysis by Technavio, “the global industrial hemp market size is estimated to grow by USD 13.90 Billion from 2024 to 2028,” and “the market is estimated to grow at a CAGR of over 25.25% during the forecast period.”

In other news out of India, senior state police officials in India recently told Al Jazeera that they have “seized about 600 tonnes of cannabis in the three years until 2023, goods worth $200m, and have also arrested 8,500 drug traffickers.”

“The police have also destroyed about 28,000 hectares (70,000 acres) of cannabis plantations in Odisha between 2021 and 2023, the highest for cannabis in the country, JN Pankaj, a former inspector general of the Special Task Force of the Odisha Police, told Al Jazeera.” the media outlet also reported.

morocco flag morocco flag morocco flag

Morocco’s Legal Industry Produced 4,000 Tons Of Cannabis In 2024

Written by Hazel Norman on . Posted in Business.

Morocco’s National Agency for the Regulation of Cannabis Activities (ANRAC) Director General Mohamed El Guerrouj recently announced at an annual board meeting that the nation’s emerging legal cannabis industry produced thousands of tons of cannabis last year.

“In 2024, approximately 4,000 tons of cannabis were produced over an area of 2,169 hectares,” ANRAC Director General Mohamed El Guerrouj stated about Morocco’s legal cannabis industry according to local reporting by APA News. “No infractions related to non-compliance were recorded.”

APA News also reported the following statistics for Morocco’s legal cannabis industry in 2024:

  • 3,371 licenses were granted out of 4,158 applications, reflecting an approval rate of nearly 81%
  • 3,056 permits were issued to 2,907 farmers for cannabis cultivation and production – up from the 430 licenses issued in 2023
  • 315 licenses were granted to 158 sector operators

The climate in parts of Morocco is well-suited for large-scale cannabis production, which is why the North African nation has long served as a leading source of unregulated cannabis, particularly as a source for the European market.

In recent years, Morocco’s government has worked to modernize the nation’s cannabis policies and regulations to permit legal cannabis production and commerce.

Currently, cannabis is legal for adult use in Uruguay, Canada, Malta, Luxembourg, Germany, and South Africa. Additionally, nearly five dozen countries have adopted medical cannabis legalization policies to some degree.

hemp plant field

Global Industrial Hemp Market To Experience Continued Growth

Written by Johnny Green on . Posted in Business.

The global market for industrial hemp and hemp-related products is far from being a new thing. Humans have valued hemp fibers and hemp seeds for thousands of years. It wasn’t until the 20th century that policies prohibiting the hemp plant were implemented.

Thankfully, more and more nations are realizing that hemp prohibition makes no sense and that it is time for a more sensible approach. Hemp policy and regulatory modernization efforts are spreading across the globe, and with it, tremendous economic opportunities are being created.

According to a recent market analysis by Technavio, “the global industrial hemp market size is estimated to grow by USD 13.90 Billion from 2024 to 2028,” and “the market is estimated to grow at a CAGR of over 25.25% during the forecast period.”

“The APAC region is a major player in the industrial hemp market, with China, Japan, and South Korea being key producers and consumers. The region’s market growth is driven by increasing product adoption in various industries and legalization of hemp cultivation in countries like China, India, Bangladesh, Japan, and Australia. China, as the largest producer, contributes significantly to the global market, with a long history of hemp use in papermaking, textiles, and medicine.” Technavio stated in its market analysis.

In a separate analysis, market analysts at Research and Markets determined that “the global market for Industrial Hemp was estimated at US$7.5 Billion in 2023 and is projected to reach US$23.3 Billion by 2030, growing at a CAGR of 17.7% from 2023 to 2030.”

“The growth in the industrial hemp market is driven by several factors, including the increasing demand for sustainable and biodegradable materials, favorable regulatory changes, and the rising popularity of CBD-based products. As industries such as automotive and construction seek eco-friendly alternatives to traditional materials, hemp’s versatility and low environmental impact make it an attractive choice. Regulatory shifts, especially the legalization of hemp cultivation in many regions, have opened new market opportunities for hemp-derived products.” Research and Markets stated about the global industrial hemp market.

In yet another market analysis, Allied Analytics found that “The global industrial hemp market size was valued at $4.9 billion in 2019, and is projected to reach $18.6 billion by 2027, registering a CAGR of 22.4% from 2021 to 2027.”

The Business Research Company also recently published a global industrial hemp market analysis, finding that, “the hemp market size is predicted to see exponential growth in just a few short years, reaching a staggering $15.08 billion by 2028, a CAGR of 20.6%.”

In its market analysis, the IMARC Group determined the following about the emerging global industrial hemp market:

  • The market is expected to reach USD 20.9 Billion by 2033, exhibiting a growth rate (CAGR) of 14.5% during 2025-2033.
  • Asia Pacific holds the largest share of the industry, driven by a large agricultural workforce, growing hemp product acceptance, and rising demand for eco-friendly, sustainable materials.
  • Hemp seeds lead the market, accounting for the majority of the market share owing to their high protein, fiber, and essential fatty acid content, appealing to health-conscious consumers.
  • Food and beverages represent the leading application segment spurred by increasing consumer demand for plant-based, sustainable, and nutrient-rich alternatives in diets.
  • The rise of hemp-based cosmetics in the beauty industry, due to its anti-inflammatory properties, is boosting the market demand.

For the hemp seed market specifically, The Business Research Company has determined that the sector “will grow from $6.71 billion in 2023 to $7.48 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%.”

“The growth in the historic period can be attributed to growing demand for plant-based protein, increasing awareness of health benefits, rising use in cosmetics and personal care products, expansion of industrial applications, and rising popularity of organic and natural products.” the researchers stated about the hemp seed market.

Regarding the global hemp protein powder market, Global Market Insights estimates that “market valuation is predicted to exceed USD 530 million by 2032.” The market analysis determined that “growth is largely fueled by the increasing demand for plant-based protein options among health-conscious consumers, including vegans and vegetarians.”

Lastly, hemp clothing continues to experience increased demand around the globe, with market researchers affiliated with Allied Analytics estimating that “the global Hemp Clothing Market Size was valued at $2.29 billion in 2021, and is projected to reach $23.02 billion by 2031, growing at a CAGR of 27.1% from 2022 to 2031.”

2024

The Top International Cannabis Stories From 2024

Written by Johnny Green on . Posted in Business, Policy.

This year was one of the biggest years in the history of the cannabis movement for both policy and industry. Below are the best international cannabis stories from 2024 (in no particular order):

German Adult-Use Legalization Enacted

The top international cannabis story from 2024 is the enactment of adult-use cannabis legalization in Germany. Starting on April 1st, 2024, adults in Germany can cultivate a personal amount of cannabis plants in their private residences and possess a personal amount of cannabis. Additionally, starting on July 1st, 2024, people can apply to launch a member-based cultivation association in Germany.

Historic Cannabis Votes In Slovenia

In conjunction with the European elections on June 9th, 2024, Slovenia voted on two consultative cannabis referendums. 66.71% of Slovenian voters approved a measure for the cultivation and processing of cannabis for medical purposes, and 51.57% voted for the cultivation and possession of cannabis for limited personal use.

South Africa Legalizes Recreational Cannabis

Back in 2018, South Africa’s Constitutional Court issued a landmark ruling that deemed cannabis prohibition as it pertained to adult individuals to be unconstitutional. This year, after a long delay, South Africa’s president signed a measure to codify the Court’s 2018 decision. Another major news story out of South Africa this year was the certification of the Cheeba Cannabis & Hemp Academy’s Higher Certificate in Cannabis Production & Management. The cannabis education program is the first on the African continent to be accredited by the Council on Higher Education.

Australian Medical Cannabis Sales Quadruple

Medical cannabis sales in Australia have quadrupled during the last two years, with Australians expected to spend an estimated $1 billion on medical cannabis in 2024. Medical cannabis was first legalized in Australia in 2016. Another major news story from Australia this year, albeit for less favorable reasons, was the failed vote on adult-use cannabis legalization.

Uruguay Adds A High-THC Strain To Legal Pharmacy Sales

Legal sales at pharmacies began in Uruguay in the summer of 2017, and consumers could initially choose from two different strains. The two strains are named ‘Alpha’ and ‘Beta’, each with tetrahydrocannabinol (THC) levels equal to or less than 9%, and cannabidiol (CBD) levels equal to or less than 3%. Then, in 2022, Uruguay permitted a third option, ‘Gamma,’ which has a THC level of equal to or less than 15%, and CBD levels of equal to or less than 1%. Regulators in Uruguay approved a fourth option in 2024 that contains a higher level of THC than the other three options.

Spain Ministry Of Health Publishes Medical Cannabis Royal Decree

The effort to bring Spain’s medical cannabis policies into the modern age passed a major milestone in 2024 with the nation’s Ministry of Health publishing a draft royal decree focused on medical cannabis. Spain is home to one of the largest cannabis communities in Europe and is in desperate need of updated cannabis laws.

Czechia Ministry Of Justice Proposes Legalization

The Ministry of Justice in the Czech Republic issued a proposal in 2024 to allow all adults to be able to cultivate up to three plants in their private residences, in addition to possessing up to 25 grams when away from their residences and up to 50 grams in their homes. Another major story from Czechia was a landmark court decision that found that a cannabis educator, Robert Veverka, was previously wrongly prosecuted for publishing cannabis education content.

Mexico Authorizes Low-THC Hemp Cultivation

Mexico’s Federal Commission for the Protection Against Sanitary Risks authorized the cultivation of low-THC hemp plants (less than 1% THC content) earlier this year. The announcement came in the form of a letter from the regulatory entity to Semillas Endemicas Mexicanna SA de CV.

Japan’s Cannabis Market Expanded Six-Fold

A new cannabis law took effect in Japan in 2024, and market researchers announced this year that Japan’s legal cannabis industry has increased six-fold in recent years. Japan’s new law that took effect in 2024 allows for the importation of certain medical cannabis products, which should further increase the size of Japan’s legal cannabis industry going forward.

Legalization Is Crushing The Unregulated Market In Canada

Health Canada released the results of its 2024 cannabis survey, and one of the main findings of this year’s survey is that only 3% of consumers “reported accessing cannabis through illegal sources,” which is a decrease from a reported 16% back in 2019.

France’s Medical Cannabis Trial Receives Another Extension

Health authorities in France announced this month that the nation’s medical cannabis trial experiment will be extended until July 31st, 2025. The announcement is welcomed news to the reported 1,800 suffering patients estimated to be currently participating in the trial.

CBD cannabis leaf plant

Legal CBD Sectors Are Set For Significant Growth

Written by Johnny Green on . Posted in Business.

The cannabis plant contains several cannabinoids, with one of the most popular ones for consumers and patients being cannabidiol (CBD). CBD is being incorporated into more recreational and medical products now than ever before, and that is leading to some eye-popping projections for the overall CBD industry and various CBD industry sectors.

According to a recent market report by Coherent Market Insights, the global CBD industry “is estimated to be valued at USD 8.12 Bn in 2024 and is expected to reach USD 23.41 Bn by 2031, exhibiting a CAGR of 16.3% from 2024 to 2031,” although, time may likely prove that projection to be too conservative as individual sector projections below will demonstrate.

A particularly popular consumption method for cannabidiol is gummies. Many consumers and patients prefer ingesting gummies versus consuming cannabidiol in forms that involve smoking or vaporization. CBD gummies are discrete and convenient, making them a great option for many people.

According to a market analysis by Straits Research, “the global CBD gummies market size was valued at USD 1.88 billion in 2024 and is projected to reach from USD 2.44 billion in 2025 to USD 19.93 billion by 2033, growing with a CAGR of 30.02% during the forecast period (2025–2033).”

“North America is the most significant global CBD gummies market shareholder and is expected to grow significantly over the forecast period. The increased prevalence of CBD-infused gummy bears within the United States can be ascribed to the escalating consumer interest in CBD merchandise and the burgeoning acceptance of alternative medicinal practices.” Straits Research also stated in its market analysis.

CBD nutraceuticals are also poised for tremendous growth in the coming years. According to market analysts at Research and Markets, “the global CBD nutraceuticals market size is expected to reach USD 23.17 billion by 2030, registering a CAGR of 14.2% from 2024 to 2030.”

Research and Markets also determined the following in its analysis:

  • CBD tinctures segment dominated the global market and accounted for a revenue share of 41.9% in 2023
  • The edibles and fortified foods segment accounted for the largest revenue share in 2023
  • North America CBD nutraceuticals market dominated the global industry with a revenue share of 54.5% in 2023

Many countries around the world are modernizing their cannabis policies and regulations to allow legal CBD commerce. Every country that does so adds further momentum to the global CBD industry.

helios cannabis munich germany

Alex Rogers Visits Cannabis Pharmacy In Munich

Written by Johnny Green on . Posted in Business.

Germany first started legally dispensing medical cannabis products through a pharmacy model back in 2017. Since that time, Germany’s medical cannabis industry has become the largest on the European continent.

Helios Cannabis is one of the leading medical cannabis companies operating in Germany and runs a medical cannabis pharmacy in Munich. Helios is comprised of an enthusiastic, committed team that deals with the topic of cannabis as a medicine and its use in the treatment of suffering patients.

Thanks to their many years of experience and continuous training, Helios provides patients with comprehensive advice and improves their quality of life. The Helios location’s model in Munich is separated into two areas – a non-cannabis pharmacy section and a medical cannabis section.

helios medical cannabis pharmacy munich germany

The Munich public prosecutor’s office conducted a search of the Helios pharmacy on Königsplatz on October 24th, 2024, accusing the location of ‘producing hash illegally.’ As legal counsel for Helios pointed out, the company is well within legal parameters to produce necessary medical cannabis products for its patients.

“Pharmacies are allowed to legally manufacture cannabis products for medical and scientific purposes. No special permission is required for this. Ensuring that the population is supplied with medicines – including cannabis – is the legal responsibility of pharmacies.” stated Konstantin Grubwinkler, legal counsel for Helios.

The recent unfounded search of the Helios location in Munich serves as an unfortunate reminder that cannabis opponents will continue to do what they can to try to thwart the progress of entities doing things the right way such as Helios.

Alex Rogers, founder and CEO of the International Cannabis Business Conference, recently visited Helios’ Munich pharmacy location to see their world-class operations firsthand. Below is a video that captures the highlights of the visit, and includes a brief discussion about the recent incident mentioned above.

college education university classes

First Cannabis Higher Education Course Receives Accreditation In Africa

Written by Johnny Green on . Posted in Business, Policy.

Earlier this year, South Africa’s president signed a measure legalizing cannabis for private use by adults. With the law’s enactment, South Africa joined Uruguay, Canada, Malta, Luxembourg, and Germany in adopting a national adult-use cannabis legalization measure.

Recently cannabis education provider Cheeba Cannabis & Hemp Academy launched its Higher Certificate in Cannabis Production & Management. The cannabis education program is the first on the African continent to be accredited by the Council on Higher Education (CHE). CHE is an internationally recognized accreditation body.

“It comes at the same time as Cheeba Africa has announced a partnership to bring its offering to Mthatha in the Eastern Cape. The economically-stressed province is hoping to see benefits from provincial government efforts to roll out an investment in the local medical cannabis industry that is expected to reach R1 billion over the next five years.” Cheeba Cannabis & Hemp Academy stated in a press release obtained by the International Cannabis Business Conference.

“It has been a rigorous four-year journey for our Academy to reach this important accreditation milestone and we’re excited to set this benchmark in cannabis education by offering this powerful programme to potential cannabis entrepreneurs and workers. It is a proud moment for our industry, and for South Africa, as we lead the way in one of the most important sectors of our time. The emerging cannabis and hemp industry has so much potential to create sustainable and dignified livelihoods in South Africa, especially in some of our most underserved communities.” states Trenton Birch, CEO and co-founder of Cheeba Africa.

The new partnership that Cheeba Cannabis and Hemp Academy has formed with the Township Cannabis Incubator (TCI) in Mthatha, Eastern Cape is a partnership that recognizes the significant potential of cannabis-related job creation and sustainable development in one of South Africa’s most rural and underserved provinces. Official unemployment rates in the Eastern Cape are above 40%, and the expanded unemployment rates are close to 50%. With 60% of the population living below the poverty level, it is recognized as one of the country’s poorest regions.

Since 2003, Training Force has delivered training to over 3,000 companies and upskilled thousands of workers across South Africa in various sectors.

“This collaboration strengthens our long-standing relationship with Cheeba, and we are excited to extend our footprint in the Eastern Cape, a region deserving of job creation and economic revitalisation.” Daniel Orelowitz, Managing Director of Training Force stated about the collaboration.

Cheeba Academy’s Higher Certificate in Cannabis Production & Management program is a 120-credit, NQF Level 5 qualification. The program will be offered at the Academy’s
flagship campus in Johannesburg making it easily accessible to students from other African countries and the world. This full-time, in-class experience which includes practical training is
designed to be one of the most unique cannabis learning opportunities in the world. Covering crucial topics such as medical cannabis, cultivation techniques, commercial operations, cannabis business, sustainable farming, futurism, and wellness, the Higher Certificate course equips students for various roles across the entire cannabis sector value chain.

The Higher Certificate in Cannabis Production & Management education program will start in early 2025. Find out more at: www.cheebaafrica.com.

International Cannabis Business Conference 2023 Auditorium Crowd

Israel Government Offers Co-Financing For Participation At ICBC Berlin 2025

Written by Johnny Green on . Posted in Business, Entertainment, Policy, Science.

The Ministry of Economy and Industry of Israel has included the International Cannabis Business Conference in Berlin 2025 as an event for which companies can receive co-financing for the cost of exhibiting or participating.

The grant falls under the Foreign Trade Administration’s “Growth for the World” program, allowing Israeli entities to apply for and reimburse up to 4K euros for expenses related to participation/exhibition at the Berlin conference, which is Europe’s largest and longest-running cannabis B2B event.

Applications to participate in the program can be submitted until December 17, 2024 at 5:00 PM. Prospective applicants can apply at this link here. The International Cannabis Business Conference is noted under the ‘Med & Bio’ category in the list of conferences for which companies can receive grants.

The Berlin conference could not be timelier, with Germany’s legal cannabis industry currently undergoing a historic expansion. Starting on April 1st, 2024, cannabis became legal for adults to cultivate, possess, and consume in Germany. Additionally, as of July 1st, 2024, aspiring cultivation association operators can apply with their local regulatory authorities in Germany.

“Europe is by far the most exciting place on the planet for cannabis policy and industry right now. Germany is leading a continental revolution and creating opportunities that we have never witnessed before and may never witness again. Entrepreneurs and investors who get in on the ground floor now could reap the benefits for generations to come.” says Alex Rogers, founder and CEO of the International Cannabis Business Conference.

The International Cannabis Business Conference is the leading cannabis B2B event series on the planet, with previous conferences occurring in several countries on multiple continents. The event series is owned and operated by cannabis advocates who believe in celebrating cannabis culture, in addition to providing world-class cannabis industry education and networking opportunities.

It is becoming increasingly difficult to gain an edge on the competition in the emerging international cannabis industry, and people need to get their ideas, products, or services in front of the right people at the right time.

With executives, entrepreneurs, investors, policymakers, and industry service providers converging from across the planet, the International Cannabis Business Conference B2B trade show event in Berlin is the perfect place to put cannabis ideas on the global cannabis stage.

Over 5,000 cannabis leaders from over 80 countries are expected to be represented at the conference in Berlin and that includes representatives from every sector of the industry as well as leading international cannabis policymakers and industry service providers.

Bring your company to the International Cannabis Business Conference in Berlin to network with the best and take your industry pursuits to the next level. Secure your exhibitor and/or sponsorship slot now before the event sells out.

Alex Rogers Cornelius Maurer The Talman Group Munich Germany 2024

The Talman House Elevates European Cannabis Investment Opportunities At Iconic Munich Event

Written by The Talman Group on . Posted in Business.

The Talman House hosted an exclusive event on November 8, 2024, at the prestigious Sofitel Munich Bayerpost. Attended by select members, this gathering offered unparalleled access to the latest data and insights on the European cannabis market, bringing together investors, industry leaders, and a diverse range of experts in a distinguished setting. Held in Munich’s historic former Bavarian Royal Post Office, the event facilitated invaluable networking and foresight for Talman House members.Peter Homberg The Talman Group Munich Germany 2024

Led by Alex Rogers, CEO of The Talman Group, and Jamie L. Pearson, international consultant for the New Holland Group, the event featured a lineup of pioneering speakers and subject-matter experts who shared insider perspectives on German and European cannabis regulations, trends, and investment opportunities. These sessions focused on strategic insights for the European market, and equipped members with a deeper understanding of this rapidly growing market.

The Talman Group Munich Germany 2024

The event opened with Max Narr, a prominent figure in Germany’s cannabis industry, who explored Germany’s transformative regulatory journey. From regulatory shifts to new pilot projects, Narr provided attendees with a unique perspective on the strategic opportunities within Germany’s evolving cannabis landscape.

In addition to Narr, a series of presentations were delivered by leading figures in the cannabis space, including:

Speakers:

  • Peter Homberg – Partner, Dentons & Head of European Cannabis Group
  • Kai-Friedrich Niermann – Founder, Kfn+ Law Office
  • Will Muecke – Co-Founding Managing Member, Artemis Growth Partners
  • Daniel Kruse – CEO, Synbiotic SE
  • Emily Fisher – Founder and CEO, Leafwell
  • David Hyde – Founder, Hyde Advisory & Investments
  • Dr. Draško Veselinovič – President of The Board, Slovenian Business & Research Association, Brussels, EU
  • Cornelius Maurer – Economist; Co-Founder and Member of the Board, Demecan
  • Giadha A. DeCarcer – Principal, Blue Onyx Horizons; Founder, New Frontier Data

Sharks:

  • George Bellow – Co-Founder, SOMAÍ Pharmaceuticals
  • Sergio Bejar Martinez – Cannabis Industry Pioneer and Entrepreneur
  • Giadha A. DeCarcer – Principal, Blue Onyx Horizons; Founder, New Frontier Data

Through a rich array of expert presentations, The Talman House underscored its commitment to delivering exclusive, high-impact opportunities that keep members at the forefront of European
cannabis investment. Attendees departed better suited and inspired to take advantage of Europe’s evolving cannabis market.

Sharks The Talman Group Munich Germany 2024

The next gathering will take place on February 21st, 2025, at the Dolder Grand in Zurich, Switzerland, presenting yet another unique opportunity for members to gain valuable insights, network with industry leaders, and stay ahead in the cannabis investment landscape.

For more information on membership and upcoming events, please visit The Talman Group’s website. Below is a recap video of The Talman House’s Munich event:

Canada Canadian Flag

Health Canada: Only 3% Of Cannabis Consumers Obtain Products From Illegal Sources

Written by Hazel Norman on . Posted in Business, Policy.

Every year since 2017, Health Canada has conducted its ‘Canadian Cannabis Survey,’ in which the government agency poses various cannabis-related questions to members of Canadian society. Canada adopted recreational cannabis legalization in 2018, and the survey helps lawmakers and regulators gain insight into how legalization has affected Canada.

Health Canada recently released the results of the 2024 survey, with data being collected from April 4th to July 2nd, 2024. The 2024 survey involved 11,666 respondents aged 16 years and older across all provinces and territories.

One of the main findings of this year’s survey is that only 3% of consumers “reported accessing cannabis through illegal sources,” which is a decrease from a reported 16% back in 2019. Many consumers reported cultivating their own cannabis and/or being gifted cannabis from friends and family. The Health Canada survey also found the following.

  • The number of respondents who reported getting cannabis from a legal source in 2024 was 72% – an increase from 37% in 2019 to 72% in 2024, with legal storefronts being the most common source since 2019.
  • There was no change in rates of cannabis use among youth (age 16-19) over the past year. Past 12-month cannabis use among youth aged 16-19 was 41%, similar to several previous years (44%, 44%, and 43% in 2019, 2020 and 2023 respectively).
  • Overall, the proportion of respondents who said they used cannabis and reported daily, or almost daily use has been stable since 2018 (approx. 25%), including among youth (approx. 20%).

“Since 2017, Health Canada has conducted the annual Canadian Cannabis Survey to better understand attitudes and knowledge regarding cannabis, as well as patterns of cannabis use in Canada. Through the information gathered, Health Canada can better understand where support is needed the most and develop program initiatives that will help educate and raise awareness around the use of cannabis.” Health Canada stated about its annual survey.

Below is a breakdown of the rates of product types reportedly consumed in 2024 in Canada according to the survey results:

  1. Dried flower/leaf (63%; down from 2018 and up from 2023)
  2. Edible cannabis (55%; up from 2018)
  3. Vape pens/cartridges (37%; up from 2018 and 2023)
  4. Oil for oral use (24%; unchanged from 2019)
  5. Beverages (21%; up from 2018)
  6. Hashish/kief (16%; down from 2018)
  7. Topical products (13%; up from 2019)
  8. Concentrates/extracts (e.g., wax, shatter or budder) (13%, down from 2018)

Canada was the second country to adopt a national adult-use cannabis legalization measure behind Uruguay (2013). Malta (2021), Luxembourg (2023), Germany (2024), and South Africa (2024) have also adopted national recreational cannabis legalization measures.

brazil flag brazil flag

Brazil’s Medical Cannabis Market Increased By 22% In 2024

Written by Johnny Green on . Posted in Business.

According to a new market report by Kaya Mind, Brazil’s emerging medical cannabis market is projected to increase by a projected 22% by the end of 2024. The market report estimates that Brazil’s medical cannabis market is worth roughly BRL 832 million ($142 million).

Kaya Mind estimates that Brazil is now home to about 672,000 medical cannabis patients, which is a 50% increase compared to 2023. The market researchers estimate that only one-third of those patients currently make their purchases legally through the nation’s pharmacies and another 22% access medical cannabis products through collectives.

According to leading international cannabis economist Beau Whitney, the overall region’s growing cannabis market is worth a considerable amount of money.

“Central and South America together are an $8 billion total market; however, its low-cost manufacturing and drive towards EU GMP and GAP certifications is making the region an attractive source of supply for the EU.” Whitney stated in a recent newsletter.

Whitney’s analysis was originally provided as part of his presentation at the inaugural Andean Hemp and Cannabis Trade Summit in October where he presented on the Central and South American hemp and cannabis markets.

In addition to the overall market value analysis, Whitney Economics also provided the following market information:

  • Five countries in Central and South America make up 89% of the regional demand
  • Brazil is home to the largest domestic market ($2.5 billion)
  • Total Central and South American market demand requires 6.3 million pounds of cultivated output
  • Peru is an estimated $0.8 – $2.2 billion domestic market
  • Peru’s hemp industry has strong opportunities in fibers, grains, and isolated cannabinoids

Brazil’s Superior Court of Justice recently ruled that cultivating, processing, and selling industrial hemp for medical and pharmaceutical uses is legal in Brazil. The decision will eventually increase options for the nation’s suffering patients.

“While the ruling is a significant victory for the medical cannabis community, Justice Regina Helena Costa emphasized that the court’s decision was limited to health-related applications.” reported Benzinga in its initial coverage of the landmark decision.

Additionally, Brazil’s National Health Surveillance Agency recently decided to amend Ordinance SVS/MS 344/1998 to allow the regulation of medical cannabis products for animals by the Ministry of Agriculture and Livestock.

Veterinarians who are approved by the nation’s Federal Council of Veterinary Medicine may prescribe registered cannabis-based medications to animals. A study from December 2022 conducted by researchers in Brazil found that, at the macro level, cannabis appears to be safe for pets, especially cannabidiol, as long as it’s administered in the right dosage level.

“The review was systematically performed in Medline (via Pubmed®) and Latin American and Caribbean Health Sciences Literature (LILACS) databases, with period restriction (between 1990 and 2021). The qualified articles (n=19), which met the previously established inclusion criteria, were critically evaluated.” stated the researchers about their study.

“Based on the literature review, it is possible to infer safety in the administration of cannabis-based products for the treatment of dogs, especially products rich in cannabidiol (CBD), free or with low concentrations of tetrahydrocannabinol, under the conditions evaluated. In addition, CBD products potentially promote improved quality of life and reduce pain perception in animals affected by canine osteoarthritis.” the researchers also stated.

“Finally, owing to the lack of large-scale and robust clinical research studies, the performance of clinical trials, considering the individual characteristics of each cannabis-based product (composition, concentration, nature of adjuvants, dosage form, route of administration), is strongly encouraged.” the researchers concluded.

mjbiz con 2024

MJBizCon Comes Back To Las Vegas On December 3-6

Written by Johnny Green on . Posted in Business.

MJBizCon, the top cannabis industry event in the United States, is coming back to Las Vegas next week on December 3rd-6th, 2024. The event, which is often described as ‘the Super Bowl of Cannabis’ is a must-attend for anyone serious about succeeding in the emerging legal U.S. industry.

Many members of the United States cannabis industry measure their calendar years from MJBizCon to MJBizCon, and rightfully so. In many ways, the event serves as a U.S. cannabis industry family reunion, with people from all over the country converging at MJBizCon to see their friends and colleagues and forge new relationships and partnerships.

Next week’s event is the thirteenth installment of the conference and will be bigger and better than ever. I was personally in attendance at the first-ever MJBizCon back in 2012, with the inaugural MJBizCon being held in Denver, Colorado the day after the state’s voters approved the nation’s first adult-use legalization measure.

I had attended other cannabis events over the years up to that point, but it was readily apparent that something special was beginning at the first MJBizCon event. Since that time, the legal industry in the United States has exploded, experiencing exponential growth across the country and the rise of the legal industry in the U.S. was paralleled by the rise of the now iconic MJBizCon.

79% of people living in the United States now live in a county with at least one regulated cannabis dispensary according to an analysis by the Pew Research Center. The Pew Research Center also found the following:

  • 74% of people in the U.S. live in a state where recreational or medical cannabis is legal
  • There are nearly 15,000 cannabis dispensaries in the U.S.
  • California has the most overall dispensaries (3,659)
  • Oklahoma has the most dispensaries per capita (36 dispensaries for every 100,000 residents)

MJBizCon has experienced such tremendous growth over the years, going from hundreds of attendees back in 2012 to tens of thousands in recent years, that the event has long since moved to its current home in Las Vegas, Nevada to accommodate the growing number of attendees and exhibitors. This year’s MJBizCon will feature (including but limited to):

  • Pre-show forums focused on finance and marketing, science and psychedelics, and women’s leadership
  • Expo Hall featuring cultivation products and services, processing, packaging and lab services, retail, and other B2B services
  • 3 full days of informative conference education sessions
  • Over 60 popular networking event opportunities

MJBizCon 2024 is expected to host over 30,000 cannabis entrepreneurs, over 1,400 exhibitors, and over 200 industry speakers.

Members of the International Cannabis Business Conference’s team will be in attendance, and we are encouraging all of our followers in the United States to consider attending MJBizCon 2024 in Las Vegas next week from December 3rd to 6th. You can purchase your tickets at this link here, and make sure to use the special promo code ‘MIPMXAB87’ to receive a special 10% discount!

The emerging legal cannabis industry in the United States is projected to add roughly $112 billion to the nation’s economy in 2024 according to an analysis by MJBiz Daily. The projection is part of the company’s 2024 MJBiz Factbook.

adult use cannabis plant

Australian Medical Cannabis Sales Quadrupled In The Last Two Years

Written by Johnny Green on . Posted in Business.

Medical cannabis sales in Australia have quadrupled during the last two years, with Australians expected to spend an estimated $1 billion on medical cannabis this year. Medical cannabis was first legalized in Australia in 2016.

“The Pennington Institute’s Cannabis in Australia report has revealed spending has skyrocketed from $230 million two years ago to a predicted $1 billion by the end of this year.” 9News stated in its local coverage.

“The spending correlates with usage, which jumped from just 3.9 per cent of survey respondents in 2019 to almost 30 per cent admitting they use prescription marijuana.” the outlet also reported.

Australia’s Senate voted on an adult-use cannabis legalization measure this week. According to the Australian Greens Party, which introduced the measure, the measure was “blocked by the Labor and Coalition parties in a 13 to 24 vote against progress.”

“We took a big step today from treating cannabis as part of the failing ‘war on drugs’ and instead putting forward a model that is safer, reduces harms and delivers for the millions of Australians who just want us to legalize it!” Greens Senator and Justice Spokesperson David Shoebridge said in a media release.

“The support for this bill across the community is enormous and it’s why we know cannabis legalisation in this country is inevitable.” Shoebridge also stated. “The Labor and Coalition parties joined together to try and hold Australia back in the 1950’s by blocking this desperately needed reform.”

Currently, cannabis is legal for adult use at a national level in Uruguay, Canada, Malta, Luxembourg, Germany, and South Africa. Cannabis is also legal for recreational use in two dozen states in the U.S., and regional adult-use cannabis commerce pilot trials are operating in the Netherlands and Switzerland.

“Government data shows 8.8 million of adult Australians have consumed cannabis. The Labor and Liberal parties are happy to call all of these people criminals. That’s a bloody disgrace.” Senator Shoebbridge said. “My office keeps hearing from people using cannabis to deal with anxiety or pain, or just to relax. We think that adults should have the right to do just that.”

“If choosing cannabis instead of products from pharmaceutical corporations is working for you, as it does for many Australians, then you should have that choice.” Shoebridge also said. “If you’d rather have a brownie than a beer, or a gummy than a cigarette, of course you should be allowed to do that.”

uruguay flag

Uruguay’s Legal Cannabis Exports Continue To Increase

Written by Hazel Norman on . Posted in Business.

Uruguay will forever hold the title of being the first country to adopt a national adult-use cannabis legalization measure. Lawmakers in Uruguay adopted recreational cannabis legalization in 2013, with legal domestic sales beginning in the nation’s pharmacies in 2017.

The South American nation is rapidly becoming a top source of legal medical cannabis products for other countries. Uruguay’s legal cannabis companies exported over $3 million worth of medical cannabis products in the last year to such nations as Germany, Portugal, Australia, New Zealand, and the United States. Uruguay’s export data is part of a new report published by the Uruguay XXI Institute.

“In 2023, Uruguayan companies exported about 25 tons of cannabis, of which 83% corresponded to medicinal flowers, with sales of USD 1.5 million.” El Planteo reported about the previous year’s statistics for contextual purposes.

The report by the Uruguay XXI Institute also determined the following:

  • Uruguay’s domestic adult-use consumer base is an estimated 250,000 people
  • The Ministry of Livestock, Agriculture, and Fisheries has issued cultivation licenses to 36 companies
  • Annual consumption of recreational cannabis in Uruguay is between 44 and 50 tons

Legal sales at pharmacies began in Uruguay in the summer of 2017, and consumers could initially choose from two different strains. The two strains are named ‘Alpha’ and ‘Beta’, each with tetrahydrocannabinol (THC) levels equal to or less than 9%, and cannabidiol (CBD) levels equal to or less than 3%.

Then, in 2022, Uruguay permitted a third option, ‘Gamma,’ which has a THC level equal to or less than 15%, and CBD levels equal to or less than 1%. Regulators in Uruguay recently approved a fourth option that contains a higher level of THC than the other three options.

“The new variant has a tetrahydrocannabinol (THC) content of equal to or less than 20% and a cannabidiol (CBD) content of equal to or less than 1%.” stated Latin America Reports in its local coverage.

“Currently, 71,843 Uruguayan citizens are legally registered to purchase cannabis in pharmacies, 11,708 have received permission to grow it at home, and 13,687 are members of cannabis clubs.” the outlet also reported.

cannabis flower bud buds

Legal Medical Cannabis Imports Surged In Q3 In Germany

Written by Johnny Green on . Posted in Business.

During the first three full months following Germany’s enactment of the CanG adult-use legalization law (Q3), legal medical cannabis imports increased by over 70% compared to the previous period. The first provisions of Germany’s CanG law, which removed cannabis from the nation’s Narcotics List, took effect on April 1st, 2024.

Germany’s Federal Institute for Drugs and Medical Devices (BfArM) recently published medical cannabis import data for Q3 2024, with the BfArM graph below showing “the total amount of cannabis imported quarterly from abroad to Germany for medical and medical-scientific purposes in the form of dried flowers (in kg )”:

BfArM dried flower cannabis imports germany Q3

“The following figure shows the total amount of cannabis imported into Germany from abroad for medical and scientific purposes in the form of dried flowers and extracts on a quarterly basis. The dried cannabis flowers are included as a weight quantity (in kg ), the extracts as a weight quantity of dried cannabis flowers (in kg ) that were required to produce the respective extracts.” states BfArM (translated from German to English):

BfArM dried flower and extracts cannabis imports germany Q3

Germany adopted a national adult-use cannabis legalization measure earlier this year. The first provisions of the law permitting personal cultivation, possession, and use went into effect on April 1st, 2024. Additionally, as another part of ‘Pillar 1’ of German legalization, cultivation associations became legal on July 1st, 2024.

‘Pillar 2’ of the nation’s legalization model involves launching regional adult-use cannabis commerce pilot trials. Such trials already operate in the Netherlands and Switzerland and are allowed under European Union law.

The German Cannabis Business Association (BvCW) recently called for no further delays in launching pilot trials in Germany to combat Germany’s unregulated market and for the nation’s new government to not regress on cannabis policies and regulations.

“Legal access options such as home cultivation, cultivation associations, but also commercial models with licensed specialist shops are the best solution to push back the black market. Therefore, a new federal government should ensure that these legal accesses to cannabis are created and maintained,” says Michael Greif, Managing Director of the BvCW. “There is no protection for young people on the black market, dealers do not ask for ID. But there are dangerous additives there. The best way to ensure youth and consumer protection is through a legal and regulated market.”

The German cannabis market is home to 4-8 million consumers with a total potential market value of between €7.8 billion and €15.6 billion according to data provided by leading economist firm Whitney Economics.

To completely supply German demand, and thus eliminate the unregulated market, Germany’s cannabis industry would need to produce over 948,000 kg of flower annually according to Whitney Economics.

cbd cannabidiol oil hemp tincture cbd cannabidiol oil hemp tincture cbd cannabidiol oil hemp tincture

U.K. Cannabidiol Market Projected To Reach Over $5 Billion In Value By 2032

Written by Johnny Green on . Posted in Business.

According to a market analysis by Vantage Market Research, the value of the United Kingdom’s emerging cannabidiol (CBD) industry is projected to reach over $5 billion by 2032. The analysis valued the U.K.’s CBD industry at $1.355 billion in 2023.

A separate analysis published in September 2024 by CLEAR found that legalizing all forms of cannabis for adult use in the United Kingdom and taxing and regulating sales could generate as much as £9.5 billion per year. However, non-CBD cannabis products are only legal in the U.K. in limited medical circumstances.

“One of the top trends in the U.K. cannabidiol market is the increasing popularity of CBD-infused wellness products, such as skincare and beauty items, driven by consumer demand for holistic health solutions.” researchers at Vantage Market Research previously stated.

Below are other findings from Vantage:

• The U.K. CBD market is rapidly expanding, driven by consumer demand for natural health solutions
• CBD-infused wellness products and beverages are gaining significant popularity
• Transparency and quality assurance are becoming crucial for consumer trust
• There is an increasing integration of CBD into traditional pharmaceuticals
• The therapeutic potential of CBD continues to drive market interest and research investments

Cannabis remains the most commonly used controlled substance in the United Kingdom, with 7.4% of adults between 16 and 59 years old in the UK reporting having used cannabis within the past year according to a 2022 report by the Office for National Statistics.

The National Centre for Social Research recently conducted a poll of United Kingdom citizens in which members of UK society were asked about their opinions regarding cannabis policy modernization efforts in the UK. The poll found a strong majority of support for legalizing cannabis sales in nearly every age group.

According to a separate analysis by The Dales Report, Germany and the United Kingdom are projected to control an estimated 77% of Europe’s emerging legal medical cannabis market by 2028.

“This growth is driven by both expanding legal frameworks and an increasing acknowledgment of the therapeutic benefits of cannabis. As both nations continue to refine their policies and commercial strategies, the focus remains on balancing patient needs with scientific and public health priorities.” The Dales Report stated about both national markets.

germany flag germany flag germany flag

Advocates Call For Cannabis Industry Expansion In Germany

Written by Johnny Green on . Posted in Business, Policy.

The German Cannabis Business Association (BvCW) is calling for the German government to embrace the nation’s emerging legal industry rather than treating people like criminals for consuming cannabis responsibly. The urging by BvCW comes amidst calls by some conservative lawmakers to roll back Germany’s recent cannabis policy changes.

“If the Union factions want to dry up the black market and fight organized crime, the cannabis industry is on their side. However, if this is to be done by criminalizing patients and consumers, this is the wrong way. It is not the users who are criminal, but the actors of the black market,” said Dirk Heitepriem, President of the BvCW, in a recent newsletter.

Germany adopted a national adult-use cannabis legalization measure earlier this year, with the first provisions of the law permitting personal cultivation, possession, and use going into effect on April 1st, 2024. Additionally, as another part of ‘Pillar 1’ of German legalization, cultivation associations became legal on July 1st, 2024.

‘Pillar 2’ of the nation’s legalization model involves launching regional adult-use cannabis commerce pilot trials. Such trials already operate in the Netherlands and Switzerland and are allowed under European Union law. BvCW is calling for no further delays in launching pilot trials in Germany to combat Germany’s unregulated market.

“Legal access options such as home cultivation, cultivation associations, but also commercial models with licensed specialist shops are the best solution to push back the black market. Therefore, a new federal government should ensure that these legal accesses to cannabis are created and maintained,” says Michael Greif, Managing Director of the BvCW. “There is no protection for young people on the black market, dealers do not ask for ID. But there are dangerous additives there. The best way to ensure youth and consumer protection is through a legal and regulated market.”

Lawmakers in Germany adopted the CanG law to boost public health outcomes by permitting adult consumers to obtain, or cultivate their own, cannabis products legally.  EU law does not permit national recreational cannabis commerce, however, it does permit regional pilot trials since they are research-based.

The German cannabis market is home to 4-8 million consumers with a total potential market value of between €7.8 billion and €15.6 billion according to data provided by leading economist firm Whitney Economics.

To completely supply German demand, and thus eliminate the unregulated market, Germany’s cannabis industry would need to produce over 948,000 kg of flower annually according to Whitney Economics. That would be impossible if Germany’s cannabis laws regressed.

“Reversing the CanG would also set Germany back considerably in international competition and in research opportunities related to cannabis,” explains Dr. Stefan Meyer, Vice President of the BvCW. “The cannabis industry in Germany has created hundreds of jobs in recent years, provided thousands of patients with access to urgently needed therapies and proven that high-quality and safe products can also be produced in Germany.”

“Regulate instead of prohibit – this should also be the motto for a new federal government. The cannabis industry is ready to work together to dry up the black market. This requires commercial opportunities to grow and sell cannabis in Germany, legal access to home-grown cannabis for consumption, safety and reliability for patients, and liberalization of industrial hemp,” said Dirk Heitepriem.

BvCW suggests that as a first step, “the Federal Ministry of Food and Agriculture could now issue the Consumer Cannabis Science Responsibility Ordinance (KCanWV).”

In the middle of the ongoing debate in Germany, the nation is hosting a multi-national conference where various leaders will share their experiences with modernizing cannabis policies and regulations, as first reported by Marijuana Moment.

“Representatives from Luxembourg, Malta, the Netherlands, the Czech Republic and Switzerland were invited by German Commissioner for Addiction and Drug Issues Burkhard Blienert to the meeting in Berlin on Monday and Tuesday to “exchange experiences in regulating cannabis for non-medical purposes.” the outlet reported.

cbd hemp leaf plant cannabis cbd hemp leaf plant cannabis cbd hemp leaf plant cannabis

UK Government Announces Reforms To Hemp License Regulations

Written by Hazel Norman on . Posted in Business, Policy.

Government officials in the United Kingdom announced this week that regulators are changing hemp licensing regulations in the country. Starting in 2025, hemp license holders in the UK will no longer have to identify a specific area on a farm property where they intend to cultivate hemp. Rather, the farmers can produce hemp anywhere on the licensed farm.

Furthermore, starting in 2026, the maximum period for a hemp production license will be increased from the current 3 years to 6 years. Hemp producers in the UK will also be able to defer the start date of cultivation by up to one year.

“These reforms will bring an important boost to this industry and cut down the unnecessary burdens that have been placed on businesses.” Dame Diana Johnson, Minister for Crime and Policing, said. “This government will always listen and engage with industry experts, and we want to make it easier for licence holders to capitalise on the economic potential of legally growing hemp.”

“These improvements to the licensing regime for industrial hemp are a positive step for farmers.” Daniel Zeichner, Minister for Food Security and Rural Affairs, said. “Recognising that industrial hemp is a field-grown agricultural crop, these reforms will simplify the license application process and provide greater flexibility within the crop rotation, enabling farmers to fully realise the economic and environmental benefits of the crop.”

In other recent hemp industry news in the United Kingdom, a government-appointed advisory panel, the Advisory Council on the Misuse of Drugs (ACMD), recommended that the UK increase the amount of tetrahydrocannabinol (THC) allowed in hemp from 0.2% to 0.3%.

“The ACMD is supportive of the proposed change to increase the maximum THC content of industrial hemp grown outdoors for seed production or in order to use the non-controlled parts of the plant to produce fibre for use in the construction and textile industries from 0.2% to 0.3%, as the potential benefits outweigh an increased risk of harms.” the panel stated.

“The ACMD recommends the Home Office to conduct an assessment of the impact of the legislative change after 2 years. The ACMD foresees no issues with applying the lower fee of £580 to a raised level of THC not exceeding 0.3%, to align with other international examples.” the panel also stated.

According to the United Kingdom government, the number of hemp licenses in the UK increased from six licenses in 2013 to 136 in 2023. A first-time hemp license in the United Kingdom costs £580. Hemp producers who apply for subsequent licenses pay £326, or less than £109 per year.

central and south america

Cannabis Industry In Central And South America Is Worth An Estimated $8 Billion

Written by Johnny Green on . Posted in Business.

Central and South America have long served as top sources for agricultural crops, and in recent years, the two regions have also emerged as top sources for legal medical cannabis products. According to leading international cannabis economist Beau Whitney, the region’s growing cannabis market is worth a considerable amount of money.

“Central and South America together are an $8 billion total market; however, its low-cost manufacturing and drive towards EU GMP and GAP certifications is making the region an attractive source of supply for the EU.” Whitney stated in a recent newsletter.

Whitney’s analysis was originally provided as part of his presentation at the inaugural Andean Hemp and Cannabis Trade Summit in October where he presented on the Central and South American hemp and cannabis markets.

In addition to the overall market value analysis, Whitney Economics also provided the following market information as part of his presentation:

  • Five countries in Central and South America make up 89% of the regional demand
  • Brazil is home to the largest domestic market ($2.5 billion)
  • Total Central and South American market demand requires 6.3 million pounds of cultivated output
  • Peru is an estimated $0.8 – $2.2 billion domestic market
  • Peru’s hemp industry has strong opportunities in fibers, grains, and isolated cannabinoids

South America will forever be home to the first country on earth to adopt a national adult-use cannabis legalization measure. Lawmakers in Uruguay approved a national recreational cannabis legalization measure in 2013, with legal sales launching in 2017. Legal adult-use sales are limited to residents of Uruguay.

Due to low labor costs and an ideal climate for outdoor cannabis cultivation, cannabis can be produced in Central and South America at a fraction of what it costs to produce in larger emerging cannabis markets, particularly in Europe. As such, legal cannabis from Central and South America will presumably be dominant in the global export market going forward.

cannabis packaging tincture oil cbd thc cannabis packaging tincture oil cbd thc cannabis packaging tincture oil cbd thc

Global Cannabis Packaging Market Projected To Reach $22.10 Billion By 2034

Written by Johnny Green on . Posted in Business.

The worldwide cannabis packing market is projected to reach $22.10 billion in value by 2034 according to a recent study conducted by Precedent Statistics. The market analysis values the cannabis packaging market at $3.49 billion in 2025.

“The market was estimated at USD 2.85 billion in 2024 and is projected to expand at a double-digit CAGR of 22.74% between 2024 and 2034.” the analysts stated.

cannabis packaging market projection 2024 to 2034

“The cannabis packaging market revolves around strong and tamper-evident packaging which provides child-resistance protection. Along with this, providing accurate information with labels and providing temperature and humidity resistance are the leading objectives of the market.” Precedent Statistics stated. The market researchers also determined the following:

  • North America holds the largest share and dominates the market due to its well-established regulations and advancement in cannabis packaging
  • Europe is a significant and mature market that drives the cannabis packaging industry by focusing on improving and adopting child-resistant features
  • Asia-Pacific is the fastest-growing market due to its versatile use and demand for the cannabis packaging market

The cannabis packaging sector of the emerging legal cannabis market is one of the most promising sectors due to every legal market requiring that cannabis products be in compliant packaging that includes such labeling information as cannabinoid content, harvest date, and/or production source.

Turkey flag

Turkey Sets Hemp Quota For Medical Products

Written by Hazel Norman on . Posted in Business, Policy.

In 2016, hemp cultivation became legal in 19 provinces in Turkey for industrial purposes. Aspiring hemp producers must obtain the country’s Ministry of Food, Agriculture, and Livestock permission before beginning operations. Hemp product permits are valid for a maximum of three years in Turkey.

Regulators in Turkey recently announced that annual hemp cultivation in the country will be limited to 5,000 square meters and 120,000 plants ‘for the production of pharmaceutical active ingredients.’ Many medical cannabis products around the globe incorporate cannabidiol derived from hemp plants.

“Exempt from these restrictions are universities, research institutes within the Ministry of Agriculture and Forestry, and organizations with research permits, which may conduct scientific and R&D projects without being subject to the quota. The Ministry of Agriculture and Forestry will oversee the allocation of the quota.” stated Daily Sabah in its local reporting.

The modern push to boost Turkey’s emerging hemp industry came in 2019 when Turkey’s president, Recep Tayyip Erdoğan, announced that the country would take steps to increase production. Turkey was experiencing an economic crisis, and increased hemp production for the purpose of medical cannabis product exports was established to try to address the problem.

Turkey has a long history of cannabis and hashish production going back many centuries, and it wasn’t until the 1970s that the country outlawed production due to pressure from the United States.

According to a recent market analysis by Spherical Insights LLP, the global industrial hemp market is projected to be worth an estimated $24.30 billion by 2033.

“The Global Industrial Hemp Market Size is to Grow from USD 5.38 Billion in 2023 to USD 24.30 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 16.27% during the projected period.” the researchers stated.

planet earth

Global Cannabidiol Market Projected To Reach $23.41 Billion By 2031

Written by Johnny Green on . Posted in Business.

According to a new report by Coherent Market Insights, the global cannabidiol (CBD) market is projected to reach $23.41 billion by 2031. The analysis predicts the worldwide CBD market will experience a compound annual growth rate (CAGR) of 16.3% from 2024 to 2031.

Interest in CBD has increased exponentially in recent years around the world, which is evidenced by how often CBD is searched on Google compared to tetrahydrocannabinol (THC). THC has historically served as the most popular cannabinoid among consumers and patients. Below is a chart demonstrating search trends for both cannabinoids in recent decades:

cbd and thc google search trends

A rise in CBD research and product availability parallels increased interest in CBD among patients and consumers. Additionally, the variety of CBD products patients and consumers can choose from has increased in recent years. CBD is now being infused into everything from edibles to topicals.

Legal CBD products are not just limited to humans. CBD products for pets are also big business these days. The global CBD pet market was worth an estimated $693.4 million in 2023 according to a recent market analysis by Global Market Insights. The CBD pet product market is projected to grow at an estimated 18.2% CAGR from 2024 to 2032.

The global market for hemp-based products is projected to reach $16.2 billion by 2033, growing at a CAGR of 24.5% between 2023 and 2033, according to a separate market analysis by Fact.MR. The researchers estimated that the market was worth $1.8 billion in 2023.

“Europe and North America collectively account for around 70% of the global market share at present and are expected to maintain a similar outlook over the coming years as well.” Fact.MR stated about its market report.

“Rapid legalization of marijuana and CBD products in these regions is expected to be a prominent factor that will help these regions sustain a dominant market share across the forecast period.” the researchers also stated.

Technavio recently published an estimate for the overall global industrial hemp industry. Technavio is a global technology research and advisory company that “focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.”

“The global industrial hemp market size is estimated to grow by USD 6.87 bn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of over 17.1% during the forecast period.” Technavio stated in a press release.